PURIFIED POLYPORUS LACCASES AND NUCLEIC ACIDS

ENCODING SAME

Field of the Invention

The present invention relates to isolated nucleic acid fragments encoding a fungal oxidoreductase enzyme and the purified enzymes produced thereby. More particularly, the invention relates to nucleic acid fragments encoding a phenol oxidase, specifically a laccase, of a basidiomycete, Polyporus.

Background of the Invention

Laccases (benzenediol:oxygen oxidoreductases) are multi-copper-containing enzymes that catalyze the oxidation of phenolics. Laccase-mediated oxidations result in the production of aryloxy-radical intermediates from suitable phenolic substrate; the ultimate coupling of the intermediates so produced provides a combination of dimeric, oligomeric, and polymeric reaction products. Such reactions are important in nature in biosynthetic pathways which lead to the formation of melanin, alkaloids, toxins, lignins, and humic acids. Laccases are produced by a wide variety of fungi, including ascomycetes such as Aspergillus, Neurospora, and Podospora, the deuteromycete Botrytis, and basidiomycetes such as Collybia, Fomes, Lentinus, PIeurotus, Trameteε, Polyporus and perfect forms of Rhizoctonia . Laccases exhibit a wide range of substrate specificity, and each different fungal laccase usually differs only quantitatively from others in its ability to oxidize phenolic substrates. Because of the substrate diversity, laccases generally have found many potential industrial

applications. Among these are lignin modification, paper strengthening, dye transfer inhibition in detergents, phenol polymerization, juice manufacture, phenol resin production, and waste water treatment. Although the catalytic capabilities are similar, laccases made by different fungal species do have different temperature and pH optima, and these may also differ depending on the specific substrate. A number of these fungal laccases have been isolated, and the genes for several of these have been cloned. For example, Choi et al . (Mol. Plant-Microbe Interactions 5.: 119-128, 1992) describe the molecular characterization and cloning of the gene encoding the laccase of the chestnut blight fungus, Cryphonectria parasitica . Kojima et al . (J. Biol. Chem. 265: 15224-15230, 1990; JP 2-238885) provide a description of two allelic forms of the laccase of the white-rot basidiomycete Coriolus hirsutus . Germann and Lerch (Experientia 11: 801,1985; PNAS USA £3.: 8854-8858, 1986) have reported the cloning and partial sequencing of the Neurospora crassa laccase gene. Saloheimo et al . (J. Gen. Microbiol. 137: 1537-1544, 1985; WO 92/01046) have disclosed a structural analysis of the laccase gene from the fungus Phlebia radiata.

Attempts to express laccase genes in heterologous fungal systems frequently give very low yields(Kojima et al., supra; Saloheimo et al., Bio/Technol. 2.: 987-990, 1991) . For example, heterologous expression of Phlebia radiata laccase in Trichoderma reesei gave only 20 mg per liter of active enzyme in lab-scale fermentation(Saloheimo, 1991, supra) . Although laccases have great commercial potential, the ability to express the enzyme in significant quantities is critical to their commercial utility. Previous attempts to express basidiomycete laccases in recombinant hosts have resulted in very low yields. The

present invention now provides novel basidiomycete laccases which are well expressed in Aspergillus .

Summary of the Invention The present invention relates to a DNA construct containing a nucleic acid sequence encoding a Polyporus laccase. The invention also relates to an isolated laccase encoded by the nucleic acid sequence. Preferably, the laccase is substantially pure. By "substantially pure" is meant a laccase which is essentially (i.e. ,≥90%) free of other non-laccase proteins.

In order to facilitate production of the novel laccase, the invention also provides vectors and host cells comprising the claimed nucleic acid sequence, which vectors and host cells are useful in recombinant production of the laccase. The sequence is operably linked to transcription and translation signals capable of directing expression of the laccase protein in the host cell of choice. A preferred host cell is a fungal cell, most preferably of the genus Aspergillus . Recombinant production of the laccase of the invention is achieved by culturing a host cell transformed or transfected with the construct of the invention, or progeny thereof, under conditions suitable for expression of the laccase protein, and recovering the laccase protein from the culture.

The laccases of the present invention are useful in a number of industrial processes in which oxidation of phenolics is required. These processes include lignin manipulation, juice manufacture, phenol polymerization and phenol resin production.

Brief Description of the Figures

Figure 1 shows the DNA sequence and translation of genomic clone 21GEN, containing LCCl (SEQ ID NO. 1)

Figure 2 shows the DNA sequence and translation of genomic clone 23GEN, containing LCC2 (SEQ ID NO. 3)

Figure 3 shows the DNA sequence and translation of genomic clone 24GEN, containing LCC3 (SEQ ID NO. 5) Figure 4 shows the DNA sequence and translation of genomic clone 31GEN, containing LCC4 (SEQ ID NO. 7)

Figure 5 shows the DNA sequence and translation of genomic clone 41GEN, containing LCC5 (SEQ ID NO. 9)

Figure 6 shows the structure of vector pMWRl Figure 7 shows the structure of vector pDSYl

Figure 8 shows the structure of vector pDSYlO

Figure 9 shows the pH profile of the laccase produced by pDSY2; (A) syringaldazine oxidation; (B) ABTS oxidation.

Figure 10 illustrates a comparison of the use of laccase vs. H ₂ 0 ₂ , with various dye precursors, in hair dyeing, as a measurement of DL*.

Figure 11 illustrates a comparison of the use of laccase vs. H ₂ 0 _2/ with various dye precursors, in hair dyeing as a measurement of Da*. Figure 12 illustrates a comparison of the use of laccase vs. H ₂ 0 ₂ , with various dye precursors and modifiers, in hair dyeing, as a measurement of DL*.

Figure 13 illustrates a comparison of the wash stability of hair dyed with laccase vs. H ₂ θ ₂ - Figure 14 illustrates the light fastness of hair dyed with laccase vs. H ₂ 0 ₂ .

Detailed Description of the Invention

Polyporus pinsitus is a basidiomycete, also referred to as Trametes villosa . Polyporus species have previously been identified as laccase producers(Fahraeus and Lindeberg,

Physiol. Plant. ____: 150-158, 1953). However, there has been no previous description of a purified laccase from Polyporus pinsitus. It has now been determined that Polyporus

pinsitus produces at least two different laccases, and the genes encoding these laccases can be used to produce relatively large yields of the enzyme in convenient host systems such as Aspergillus . In addition, three other genes which appear to code for laccases have also been isolated. Initial screenings of a variety of fungal strains indicate that Polyporus pinisitus is a laccase producer. Th production of laccase by P. pinsitus is induced by 2,5- xylidine. Attempts are first initiated to isolate the laccase from the supernatant of the induced strains. Anion exchange chromatography identifies an approximately 65 kD(o SDS-PAGE) protein which exhibits laccase activity. The enzyme is purified sufficiently to provide several internal peptide sequences, as well as an N-terminal sequence. The initial sequence information indicates the laccase has significant homology to that of Coriolus hirsutus, as well as to an unidentified basidiomycete laccase (Coll et al., Appl. Environ. Microbiol. j59_: 4129-4135, 1993. Based on th sequence information, PCR primers are designed and PCR carried out on cDNA isolated from P. pinsitus . A band of the expected size is obtained by PCR, and the isolated fragment linked to a cellulase signal sequence is shown to express an active laccase in A. oryzae, but at low levels. One of the PCR fragments is also used as a probe in screening a P. pinsitus cDNA library. In this manner, more than 100 positive clones are identified. The positive clones are characterized and the ends of the longest clones sequenced; none of the clones are found to be full-length. Further attempts to isolate a full length clone are made. A 5-6 kb BamHI size-selected P. pinsi tus genomic library is probed with the most complete cDNA fragment isolated as described above. Initial screening identifies one clone 24GEN(LCC3) having homology to the cDNA, but which is not the cDNA-encoded laccase and also not full length.

Subsequent screening of a 7-8kb BamHI/EcoRi size-selected library indicates the presence of at least two laccases; partial sequencing shows that one, called 21GEN(LCC1), is identical to the original partial cDNA clone isolated, and the second,called 31GEN(LCC4) is a new, previously unidentified laccase. Secondary screenings of an EMBL4 genomic bank with LCC1 as probe identifies a class of clone containing the entire LCC1 insert as well as the 5' and 3 ' flanking regions. Screening of the EMBL bank with LCC3 identifies two additional clones encoding laccases which had not previously been identified,41GEN(LCC5) and 23GEN(LCC2) and which differed structurally from the other three clones LCCl, LCC3, and LCC4. The nucleic acid and predicted amino acid sequences of each of the laccases is presented in Figures 1-5, and in SEQ ID NOS. 1-10. A comparison of the structural organization of each of the laccases is presented in Table 2. The laccases are generally optimally active at acid pH, between about 4-5.5.

LCCl is used to create expression vectors, which are in turn used to transform various species of Aspergillus.

Transformation is successful in all species tested, although expression levels are highest in Aspergillus niger. Shake flask cultures are capable of producing 15 or more mg/liter of laccase, and in lab-scale fermentors, yields of over 300mg/liter are observed. This is a significant improvement over laccase levels observed previously with other laccases and other fungal host cells.

According to the invention, a Polyporus gene encoding a laccase can be obtained by methods described above, or any alternative methods known in the art, using the information provided herein. The gene can be expressed, in active form, using an expression vector. A useful expression vector contains an element that permits stable integration of the vector into the host cell genome or autonomous replication

of the vector in a host cell independent of the genome of the host cell, and preferably one or more phenotypic marker which permit easy selection of transformed host cells. The expression vector may also include control sequences encoding a promoter, ribosome binding site, translation initiation signal, and, optionally, a repressor gene or various activator genes. To permit the secretion of the ex¬ pressed protein, nucleotides encoding a signal sequence may be inserted prior to the coding sequence of the gene. For expression under the direction of control sequences, a laccase gene to be used according to the invention is operably linked to the control sequences in the proper reading frame. Promoter sequences that can be incorporated into plasmid vectors, and which can direct the transcriptio of the laccase gene, include but are not limited to the prokaryotic β-lactamase promoter (Villa-Kamaroff, et al., 1978, Proc. Natl. Acad. Sci. U.S.A. 7ϋ:3727-3731) and the tac promoter (DeBoer, et al., 1983, Proc. Natl. Acad. Sci. U.S.A. &0_:21-25) . Further references can also be found in "Useful proteins from recombinant bacteria" in Scientific American, 1980,, 242:74-94; and in Sambrook et al., Molecula Cloning, 1989.

The expression vector carrying the DNA construct of th invention may be any vector which may conveniently be subjected to recombinant DNA procedures, and the choice of vector will typically depend on the host cell into which it is to be introduced. Thus, the vector may be an autonomousl replicating vector, i.e. a vector which exists as an extrachromosomal entity, the replication of which is independent of chromosomal replication, e.g. a plasmid, or an extrachromosomal element, minichromosome or an artificia chromosome. Alternatively, the vector may be one which, whe introduced into a host cell, is integrated into the host

cell genome and replicated together with the chromosome(s) into which it has been integrated. in the vector, the laccase DNA sequence should be opera bly connected to a suitable promoter sequence. The promoter may be any DNA sequence which shows transcriptional activity in the host cell of choice and may be derived from genes encoding proteins either homologous or heterologous to the host cell. Examples of suitable promoters for directing the transcription of the DNA construct of the invention, especially in a bacterial host, are the promoter of the lac operon of E. coli , the Streptomyces coelicolor agarase gene dagA promoters, the promoters of the Bacillus licheniformis α-amylase gene (airiyL) , the promoters of the Bacillus stearothermophilus maltogenic amylase gene (amyM) , the promoters of the Bacillus amyloliquefaciens α-amylase

(amyQ) , or the promoters of the Bacillus subtilis xylA and xylB genes. In a yeast host, a useful promoter is the eno-1 promoter. For transcription in a fungal host, examples of useful promoters are those derived from the gene encoding A . oryzae TAKA amylase, Rhizomucor miehei aspartic proteinase,

A. niger neutral α—amylase, A. niger acid stable α-amylase,

A. niger or A . awamori glucoamylase { glaA) , Rhizomucor miehei lipase, A. oryzae alkaline protease, A. oryzae triose phosphate isomerase or A. nidulans acetamidase. Preferred are the TAKA-amylase and glaA promoters.

The expression vector of the invention may also comprise a suitable transcription terminator and, in eukaryotes, polyadenylation sequences operably connected to the DNA sequence encoding the laccase of the invention. Termination and polyadenylation sequences may suitably be derived from the same sources as the promoter. The vector may further comprise a DNA sequence enabling the vector to

replicate in the host cell in question. Examples of such sequences are the origins of replication of plasmids pUC19, PACYC177, pUBllO, pEl94, pAMBl and pIJ702.

The vector may also comprise a selectable marker, e.g. a gene the product of which complements a defect in the hos cell, such as the dal genes from B. subtilis or B. li - cheniformis, or one which confers antibiotic resistance suc as ampicillin, kanamycin, chloramphenicol or tetracycline resistance. Examples of Aspergillus selection markers include amdS, pyrG, argB, niaD, sC, trpC and hygB, a marker giving rise to hygromycin resistance. Preferred for use in an Aspergillus host cell are the amdS and pyrG markers of A nidulans or A. oryzae. A frequently used mammalian marker i the dihydrofolate reductase (DHFR) gene. Furthermore, selection may be accomplished by co-transformation, e.g. as described in WO 91/17243.

It is generally preferred that the expression gives rise to a product which is extracellular. The laccases of the present invention may thus comprise a preregion permitting secretion of the expressed protein into the culture medium. If desirable, this preregion may be native to the laccase of the invention or substituted with a diffe ent preregion or signal sequence, conveniently accomplished by substitution of the DNA sequences encoding the respectiv preregions. For example, the preregion may be derived from a glucoamylase or an amylase gene from an Aspergillus species, an amylase gene from a Bacillus species, a lipase or proteinase gene from Rhizomucor miehei , the gene for the α-factor from Saccharomyces cerevisiae or the calf preprochymosin gene. Particularly preferred, when the host is a fungal cell, is the signal sequence for A. oryzae TAKA amylase, A. niger neutral amylase, the Rhizomucor miehei

aspartic proteinase signal, the Rhizomucor miehei lipase signal, the maltogenic amylase from Bacillus NCIB 11837, B. stearothermophilus α-amylase, or B. licheniformis subtilisin. The procedures used to ligate the DNA construct of the invention, the promoter, terminator and other elements, respectively, and to insert them into suitable vectors containing the information necessary for replication, are well known to p.ersons skilled in the art (cf., for instance, Sambrook et al. Molecular Cloning, 1989).

The cell of the invention either comprising a DNA construct or an expression vector of the invention as defined above is advantageously used as a host cell in the recombinant production of a enzyme of the invention. The cell may be transformed with the DNA construct of the invention, conveniently by integrating the DNA construct in the host chromosome. This integration is generally con¬ sidered to be an advantage as the DNA sequence is more likely to be stably maintained in the cell. Integration of the DNA constructs into the host chromosome may be performed according to conventional methods, e.g. by homologous or heterologous recombination. Alternatively, the cell may be transformed with an expression vector as described above in connection with the different types of host cells.

The host cell may be selected from prokaryotic cells, such as bacterial cells. Examples of suitable bacteria are gram positive bacteria such as Bacillus subtilis, Bacillus licheniformis, Bacillus lentus, Bacillus brevis, Bacillus stearothermophilus, Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus coagulans, Bacillus circulans, Bacillus lautuε, Bacillus megaterium, Bacillus thuringiensis, or Streptomyces lividans or Strep tomyces

murinus , or gram negative bacteria such as E. coli . The transformation of the bacteria may for instance be effected by protoplast transformation or by using competent cells in a manner known per se. The host cell may also be a eukaryote, such as mammalian cells, insect cells, plant cells or preferably fungal cells, including yeast and filamentous fungi. For example, useful mammalian cells include CHO or COS cells. A yeast host cell may be selected from a species of Saccharomyces or Schizosaccharomyces, e.g. Saccharomyces cerevisiae. Useful filamentous fungi may be selected from a species of Aspergillus, e.g. Aspergillus oryzae or Aspergillus niger. Alternatively, a strain of a Fusarium species, e.g. F. oxysporum, can be used as a host cell. Fungal cells may be transformed by a process involving proto plast formation and transformation of the protoplasts fol¬ lowed by regeneration of the cell wall in a manner known per se. A suitable procedure for transformation of Aspergillus host cells is described in EP 238 023. A suitable method of transforming Fusarium species is described by Malardier et al., 1989.

The present invention thus provides a method of producing a recombinant laccase of the invention, which method comprises cultivating a host cell as described above under conditions conducive to the production of the enzyme and recovering the enzyme from the cells and/or culture medium. The medium used to cultivate the cells may be any conventional medium suitable for growing the host cell in question and obtaining expression of the laccase of the invention. Suitable media are available from commercial suppliers or may be prepared according to published formulae (e.g. in catalogues of the American Type Culture Collection) .

In a preferred embodiment, the recombinant production of laccase in culture is achieved in the presence of an excess amount of copper. Although trace metals added to the culture medium typically contain a small amount of copper, experiments conducted in connection with the present invention show that addition of a copper supplement to the medium can increase the yield of active enzyme many-fold. Preferably, the copper is added to the medium in soluble form, preferably in the form of a soluble copper salt, such as copper chloride, copper sulfate, or copper acetate. The final concentration of copper in the medium should be in the range of from 0.2-2mM, and preferably in the range of from 0.05-0.5mM. This method can be used in enhancing the yield of any recombinantly produced fungal laccase, as well as other copper-containing enzymes, in particular oxidoreductases.

The resulting enzyme may be recovered from the medium by conventional procedures including separating the cells from the medium by centrifugation or filtration, precipitat- ing the proteinaceous components of the supernatant or fil¬ trate by means of a salt, e.g. ammonium sulphate, followed by purification by a variety of chromatographic procedures, e.g. ion exchange chromatography, gel filtration chromatography, affinity chromatography, or the like. Preferably, the isolated protein is about 90% pure as determined by SDS-PAGE, purity being most important in food, juice or detergent applications.

In a particularly preferred embodiment, the expression of laccase is achieved in a fungal host cell, such as Aspergillus . As described in detail in the following examples, the laccase gene is ligated into a plasmid containing the Aspergillus oryzae TAKA α-amylase promoter, and the Aspergillus nidulans amdS selectable marker. Alternatively, the amdS may be on a separate plasmid and

used in co-transformation. The plasmid (or plasmids) is used to transform an Aspergillus species host cell, such as A. oryzae or A., niger in accordance with methods described in Yelton et al. (PNAS USA 81: 1470-1474,1984). It is of particular note that the yields of Polyporus laccase in the present invention, using Aspergillus as host cell are unexpectedly and considerably higher than has previously been reported for expression of other laccases in other host cells. It is expected that the use of Aspergillus as a host cell in production of laccases from other basidiomycetes, such as Coriolus or Trametes, will also produce larger quantities of the enzyme than have been previously obtainable. The present invention therefore also encompasses the production of such Polyporus -like laccases in Aspergillus recombinant host cells.

Those skilled in the art will recognize that the invention is not limited to use of the nucleic acid fragments specifically disclosed herein, for example, in Figures 1-5. It will also be apparent that the invention encompasses those nucleotide sequences that encode the same amino acid sequences as depicted in Figure 1-5, but which differ from the specifically depicted nucleotide sequences by virtue of the degeneracy of the genetic code. Also, reference to Figures 1-5 in the specification and the claims will be understood to encompass both the genomic sequence depicted therein as well as the corresponding cDNA and RNA sequences, and the phrases "DNA construct" and "nucleic acid sequences" as used herein will be understood to encompass all such variations. "DNA construct" shall generally be understood to mean a DNA molecule, either single- or double- stranded, which may be isolated in partial form from a naturally occurring gene or which has been modified to contain segments of DNA which are combined and juxtaposed in a manner which would not otherwise exist in nature.

In addition, the invention also encompasses other Polyporus laccases, including alternate forms of laccase which may be found in Polyporus pinsi tus and as well as laccases which may be found in other fungi falling within the definition of Polyporus as defined by Fries, or synonyms thereof as stated in Long et al., 1994, ATCC Names of Industrial Fungi, ATCC, Rockville, Maryland. Identification and isolation of laccase genes from sources other than those specifically exemplified herein can be achieved by utilization of the methodology described in the present examples, with publicly available Polyporus strains. Alternately, the sequence disclosed herein can be used to design primers and/or probes useful in isolating laccase genes by standard PCR or southern hybridization techniques. Other named Polyporus species include, but are not limited to, P. zonatus, P. alveolaris, P. arcularius, P. australiensis, P. badius, P. biformis, P. brumalis, P. ciliatus, P. colensoi, P. eucalyptoxrum, P. meridionaliε, P. varius, P. palustris, P. rhizophilus, P. rugulosus, P. squamosus , P. tuberaster , and P. tumulosuε . Also encompassed are laccases which are synonyms, e.g., anamorphs or perfect states of species or strains of the genus Polyporus . Strains of Polyporus are readily accessible to the public in a number of culture collections, such as the American Type Culture Collection (ATCC), e.g., ATCC 26721, 9385, 11088, 22084, Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM),e.g., DSM 1021, 1023, and 1182; and Centraalbureau Voor Schimmelcultures (CBS), e.g., CBS 678.70, 166.29, 101.15, 276.31, 307.39, 334.49, and 332.49. The invention also encompasses any variant nucleotide sequence, and the protein encoded thereby, which protein retains at least about an 80% homology, preferably at least about 85%, and most preferably at least about 90-95% homology with any one of the amino acid sequences depicted

in Figures 2-5, and which qualitatively retains the laccase activity of the sequence described herein. Useful variants within the categories defined above include, for example, ones in which conservative amino acid substitutions have been made, which substitutions do not significantly affect the activity of the protein. By conservative substitution is meant that amino acids of the same class may be substituted by any other of that class. For example, the nonpolar aliphatic residues Ala, Val, Leu, and lie may be interchanged, as may be the basic residues Lys and Arg, or the acidic residues Asp and Glu. Similarly, Ser and Thr are conservative substitutions for each other, as are Asn and Gin. It will be apparent to the skilled artisan that such substitutions can be made outside the regions critical to the function of the molecule and still result in an active enzyme. Retention of the desired activity can readily be determined by conducting a standard ABTS oxidation method, such as is described in the present examples.

The protein can be used in number of different industrial processes. These processes include polymerizatio of lignin, both Kraft and lignosulfates, in solution, in order to produce a lignin with a higher molecular weight. Such methods are described in, for example, Jin et al., Holzforschung 45(6) : 467-468, 1991; US Patent No. 4,432,921; EP 0 275 544; PCT/DK93/00217, 1992.

The laccase of the present invention can also be used for in-situ depolymerization of lignin in Kraft pulp, thereby producing a pulp with lower lignin content. This use of laccase is an improvement over the current use of chlorine for depolymerization of lignin, which leads to the production of chlorinated aromatic compounds, which are an environmentally undesirable by-product of paper mills. Suc uses are described in, for example, Current opinion in

Biotechnology 2: 261-266, 1992; J. Biotechnol. 25.: 333-339, 1992; Hiroi et al. , Svensk papperstidning .5: 162-166, 1976.

Oxidation of dyes or dye precursors and other chromophoric compounds leads to decolorization of the compounds. Laccase can be used for this purpose, which can be particularly advantageous in a situation in which a dye transfer between fabrics is undesirable, e.g., in the textile industry and in the detergent industry. Methods for dye transfer inhibition and dye oxidation can be found in WO 92/01406, WO 92/18683, EP 0495836 and Calvo, Mededelingen van de Faculteit Landbouw-wetenschappen/Rijiksuniversitet Gent.5L: 1565-1567, 1991; Tsujino et al., J. Soc. Chem.12.: 273-282, 1991.

The laccase is particularly well-suited for use in hair dyeing. In such an application, the laccase is contacted with a dye precursor, preferably on the hair, whereby a controlled oxidation of the dye precursor is achieved to convert the precursor to a dye, or pigment producing compound, such as a quinoid compound. The dye precursor is preferably an aromatic compound belonging to one of three major chemical families: the diamines, aminophenols (or aminonaphthols) and the phenols. The dye precursors can be used alone or in combination. At least one of the intermediates in the copolymerization must be an ortho- or para-diamine or aminophenol (primary intermediate). Examples of such are found in Section V, below, and are also described in US Patent No. 3,251,742, the contents of which are incorporated herein by reference. In one embodiment, the starting materials include not only the enzyme and a primary intermediate, but also a modifier(coupler) (or combination of modifiers) , which modifier is typically a meta-diamine, meta-aminophenol, or a polyphenol. The modifier then reacts with the primary intermediate in the presence of the laccase, converting it to a colored

compound. In another embodiment, the laccase can be used with the primary intermediate directly, to oxidize it into a colored compound. In all cases, the dyeing process can be conducted with one or more primary intermediates, either alone or in combination with one or more modifiers. Amounts of components are in accordance with usual commericial amounts for similar components, and proportions of , components may be varied accordingly.

The use of this laccase is an improvement over the more traditional use of H ₂ 0 ₂ , in that the latter can damage the hair, and its use usually requires a high pH, which is also damaging to the hair. In contrast, the reaction with laccase can be conducted at alkaline, neutral or even acidic pH, and the oxygen needed for oxidation comes from the air, rather than via harsh chemical oxidation. The result provided by the use of the Polyporus laccase is comparable to that achieved with use of H ₂ 0 ₂ , not only in color development, but also in wash stability and light fastness.

An additional commercial advantage is that a single container package can be made containing both the laccase and the precursor, in an oxygen free atmosphere, which arrangement is not possible with the use of H ₂ 0 ₂ .

The present laccase can also be used for the polymerization of phenolic or aniline compounds present in liquids. An example of such utility is the treatment of juices, such as apple juice, so that the laccase will accelerate a precipitation of the phenolic compounds present in the juice, thereby producing a more stable juice. Such applications have been described in Stutz, Fruit processing 7/93. 248-252, 1993; Maier et al. , Dt. Lebensmittel- rindschau fij5I_.il: 137-142, 1990; Dietrich et al., Fluss. Obst 57(2) : 67-73, 1990.

Laccases such as the Polyporus laccase are also useful in soil detoxification (Nannipieri et al., J. Environ. Qual.

20: 510-517,1991; Dec and Bollag, Arch. Environ. Contam. Toxicol. 1£: 543-550, 1990).

The invention is further illustrated by the following non-limiting examples. EXAMPLES

I. ISOLATION OF A POLYPORUS PINISITUS LACCASE ENZYME MATERIALS AND METHODS

1. Enzymatic assays

Unless otherwise stated, throughout the examples, laccase activity is determined by syringaldazine and 2,2'- bisazino(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) , as follows. The oxidation of syringaldazine is monitored at 530 nm with 19 μM substrate. In 25 mM sodium acetate, 40 μM cupric sulfate, pH 5.5, at 30'C, the activity is expressed as LACU(μmole/min) . For pH profile studies, Britton &

Robinson(B&R) buffers are used, and are prepared according to the protocol described in Quelle, Biochemisches Taschenbuch, H.M. Raven, II. Teil, S.93 u. 102, 1964. ABTS oxidation is carried out with ImM ABTS in 0.1 M NaAc, pH 5.0 at room temperature by monitoring either ΔAbs ₄₀₅ in a 96-well plate(Costar) or ΔAbs ₄₁₈ in a quartz cuvette. The overlay

ABTS oxidase activity assay is carried out by pouring cooled ABTS-agarose(0.03-0.1 g ABTS, 1 g agarose, 50 ml H ₂ 0, heated to dissolve agarose) over a native IEF gel or PAGE and incubating at room temperature.

2. Initial isolation of laccase

In order to isolate the laccase, 800 ml of culture fluid is filtered by HFSC on a Supra filter(slow filtering). The clear filtrate is then concentrated and washed on an Amicon cell with a GR81 PP membrane to a volume of 72 ml.

One ml aliquots of laccase are bound to a Q-sepharose HP(Pharmacia, Sweden) column, equilibrated with 0.1 M phosphate, pH7 and the laccase is eluted with a NaCl gradient. In all, 10 x 1 ml samples are purified, pooled,

concentrated and washed by ultrafiltration using a membrane with a molecular weight cut-off of 6kD.

3. Secondary purification

In a second purification, a fermentation broth is filtered and concentrated by ultrafiltration. The starting material contains 187 LACU/ml. The concentrate is quick- filtered on a Propex 23 filter(P & S Filtration), with 3% Hyflo Cuper-Cel(HSC; Celite Corporation), followed by two ultrafiltration on a Filtron filter with two membranes, each with a molecular weight cutof of 3 kD. The resulting sample (2.5 mS/cm, pH 7.0, at 4'C) is applied to a 130 ml Q- Sepharose column, equilibrated with sodium phosphate, 1.1 mS/cm, pH 7.0. Under these conditions the laccase does not bind to the column, but elutes slowly from the column during the application and wash with the equilibration buffer, resulting in a partial separation from other brownish material.

This partially purified preparation of l.OmS, pH 7.0 at 20'C is applied to a Q-sepharose column. The column is equilibrated with 20mM sodium phosphate, 2.2 mS, pH 7.0.

Under these conditions, the laccase binds to the column and is eluted by a gradient of 0-1 M NaCl over 20 column volumes.

3. Sequencing For internal peptide sequencing, the purified protein is digested with trypsin, followed by peptide purification with HPLC. Purified peptides are sequenced in an Applied Biosyste s 473A sequencer.

B. RESULTS AND DISCUSSION 1.Initial characterization

Total yield of the initial purification is about 50 mg(estimated at A280nm) . The purified enzyme has a rich blue color, and appears as only two very close bands on SDS- PAGE at about 65 kd. A native PAGE overlaid with substrate

shows that both bands have laccase activity with ABTS. The absorption spectrum shows that besides an absorption at A280nm, the purified laccase also shows absorption at about 600nm. 2. Sequencing

A N-terminal determination of the protein initially purified shows a single sequence:

Gly-Ile-Gly-Pro-Val-Ala-Asp-Leu-Thr-Ile-Thr-Asn- Ala-Ala-Ala-Val-Ser-Pro-Asp-Gly-Phe-Pro... Since the N-terminal sequence is not the ideal sequence for constructing a probe, additional experiments with a trypsin digest are conducted, followed by further purificatio (described above) and sequencing of fragments

2. Secondary purification and characterization In the second purification, the second Q-Sepharose chromatographic step yields the following pools:

Q-Sepharose-2-pool-l 40 ml 112 LACU 47 LACU/A ₂₈ o

Q-Sepharose-2-pool-3 80 ml 385 LACU 65 LACU/A ₂₈ o

The elution yields >80% of the applied amount. The highly purified preparation Q-Sepharose-2-pool-3 has an A ₂ so = 5.9, and A ₂ 8o ^A 260 = 1-4. The purity of the laccase in the starting material is extremely high on a protein basis but the starting material is a very dark brown color. In SDS- PAGE, a double band is seen, with a dominating 65 kD band and a smaller 62 kD band. By anionic chromatography, only the dominating band is seen in the first peak(Q-Sepharose-2- pool-1) , whereas both bands are seen in the second peak(Q- Sepharose-2-pool-3) .

3. Sequence A number of internal peptide sequences are determined, and compared with the Coriolus hirsutus (Ch) laccase sequence. The identified fragments are as follows: Tryp 13: Ser-Pro-Ser-Thr-Thr-Thr-Ala-Ala-Asp-Leu

Tryp 14:

Ser-Ala-Gly-Ser-Thr-Val-Tyr-Asn-Tyr-Asp-Asn-Pro-Ile-Phe Arg

Tryp 16:

Sequence 1: Ser-Thr-Ser-Ile-His-Trp-His-Gly-Phe-Phe-Gln-Lys

Sequence 2:

Gly-Ile-Gly-Pro-Val-Ala-Asp-Leu-Thr-lle-Thr-Asn-Ala-Ala-V al

Tryp 18:

Gly-Ile-Gly-Pro-Val-Ala-Asp-Leu-Thr-lle-Thr-Asn Tryp 19:

Sequence 1:

Leu-Gly-Pro-Ala-Phe-Pro-Leu-Gly-Ala-Asp-Ala-Thr-Leu-Ile-

Sequence 2:

Phe-Gln-Leu-Asn-Val-Ile-Asp-Asn-Asn-Thr-Thr-His-Thr-Met Tryp 25:

Tyr-Ser-Phe-Val-Leu-Glu-Ala-Asn-Gln-Ala-Val-Asp-Asn-Tyr-T rp-

Ile-Arg

Tryp 27

Gly-Thr-Asn-Trp-Ala-Asp-Gly-Pro-Ala-Phe II. ISOLATION OF A POLYPORUS PINISITUS LACCASE CDNA CLONE A. MATERIALS AND METHODS

1. RNA preparation

RNA is isolated from 10 grams of P. pinsitus mycelium grown under xylidine induction for 6.5 hours, using the guanidium/CsCl cushion method. The RNA is poly-A selected on an oligo-dT column, using standard conditions. 120μg mRNA is obtained and stored as lyophilized pellet in 5μg aliquots at -80"C.

2. Single stranded cDNA Single stranded cDNA is synthesized using the reverse transcriptase "Super Script" (BRL) according to manufacturer' s directions.

3. Construction of cDNA library

A cDNA library is constructed using the librarian IV cDNA kit (Invitrogen) . Fifty cDNA pools, each containing approximately 5000 individual transformants, are obtained. 4. PCR PCR is conducted under the following standard conditions: lOOpmol of each primer, lOμl 10X PCR buffer(Perkin-Elmer) , 40μl dNTP 0.5 mM, 2μl single stranded cDNA(or approximately 100 ng chromosomal DNA or 100 ng PCR fragment), H ₂ 0 to 100 μl, 2.5U Taq polymerase. The cycles are 3x(40'C/two minutes, 72 ^* C/two minutes, 94'C/one minute) followed by 30x(60 ^* C/two minutes, 72'C/two minutes, 94'C/l minute) . B. RESULTS AND DISCUSSION

1. Cloning of PolvOorus vinsi tus laccase PCR is carried out with the primer #3331:

ACCAGNCTAGACACGGGNTC/AGATACTG/ACGNGAGAGCGGAC/TTGCTGGTC

ACTATCTTCGAAGATCTCG and primer #3332:

CGCGGCCGCTAGGATCCTCACAATGGCCAA/CTCTCTG/CCTCG/ACCTTC. A clear band of about 1500bp is obtained. The DNA is digested with Notl/Hindlll, and fractionated on an agarose gel. The upper band(fragment #42) is purified and cloned into the Aspergillus vector pHD423. No transformants are obtained. Several attempts are carried out in order to clone the fragment, including redigestion with the restriction enzymes, phosphorylation of the ends, filling in with klenow and blunt-end cloning in Smal cut puClδ, without success. Hybridization with a laccase probe based on the laccase described in Coll et al., supra, indicates that the PCR product could be the P. pinsitus laccase. In a new attempt to clone the PCR fragment, ^' a new PCR reaction is carried out, using the same conditions as for fragment #42. Again the result is a fragment of about 1500 bp(fragment #43). This time the fragment is cut with HindiII/BamHI, and

ligated to HindiII/BamHI-cut pUClδ. Three clones, #43-/A,- B,-G are found to contain a fragment of 1500 bp. Partial sequencing reveals that these fragments are laccase related. 2.Expression of Polγporus insitus laccase To express the laccase, the fragment #43 is joined to a signal sequence from a 43kD cellulase. The primer pHD433 (TAGCGGATCCCACAATGCGTTCCTCCCCCCTCCTCCCGTCCGCCGTTGTGGCCGCCCTG CCGGTGTTGGCCCTTGCCGGCATTGGGCCCGTCGCGGACC) is used in a standard PCR reaction with a pUC forward primer(New England Biolabs) . All three clones are used as templates in order to minimize the risk of working with DNA containing errors. The PCR generated DNA from the reaction with a primer PHD433 and template 43-A and 43-G is cut with Hindlll/BamHI and cloned into the Aspergillus expression vector pHD414(described in detail below). Several transformants are obtained.

Clones pHD433/43A-l,2, pHD433/43G-2,-3 are transformed into A. oryzae. The transformants from each transformation (between 3-10) are analyzed for laccase production. Activity is only obtained with pHD433/43G-3. The positive transformants (numbers 1, 4, 6) are reisolated on amdS plates, and retested. In an additional transformation round a further ten transformants are obtained with pHD433/43G-3. The clones #20, 23, 26, 28, and 29 are positive. The clones are reisolated and two single isolates are analyzed for laccase expression semiquantitatively by color development in an ABTS assay at pH 4.5. On a scale of +-+++, several clones show moderate to strong expression of laccase.

Further cloning is conducted to identify a full length clone. A xylidine-induced cDNA library consisting of approximately 350,000 transformants is screened using fragment #42-4 as a probe. More than 100 positive clones are detected. The clones are purified, rescreened, and analyzed on Southern blots. Two of the longest clones are

further characterized by DNA sequence determination. The longest clones are found to be identical and found to contain a poly-A stretch in the 3 ' end and to start at the amino acid number 4 in the amino terminus. A partial DNA sequence is determined from different clones. pHD433/43G-3 is then used in further cloning studies as described in the following Section IV. III. PURIFICATION AND CHARACTERIZATION OF ADDITIONAL POLYPORUS PINSITUS LACCASE WILD-TYPE ENZYMES A. MATERIALS AND METHODS 1.Culture conditions

Shake flasks (250 ml medium/2.8 1 baffled flask)are inoculated wtih several agar plugs taken from a week-old PDA plate of P. pinsitus . The medium contains, per liter, 10 g glucose, 2.5 g L-asparagine, 0.2 g L-phenylalanine, 2.0 g yeast extract, 2.0 g KH ₂ P0 ₄ , 0.5 g MgS0 ₄ -7H 0, 2.0 mlAMG trace metals, 0.002 g CuS0 ₄ -7H ₂ 0, 1.0 g citric acid, made with tape water, pH 5.0 before autoclaving. The cultures are grown at 18-22'C on a rotary shaker with low agitiation (-100 rpm) . After 7 days, the pH of each shake flask is adjusted to -6.0 by the addition of 0.25 ml 5 N NaOH and the cultures are induced by adding 0.5 ml of a 2,5-xylidine stock solution(xylidine diluted 1:10 into ethanol) to each flask. Flasks are incubated for an additional 24 hours, at which time the culture supernatant from each flask is recovered. 2. Materials.

Chemicals used as buffers are commercial products of at least reagent grade. Endo/N-glucosidase F is from Boehringer-Mannheim. Chromatography is performed on Pharmacia FPLC. Spectroscopic assays are conducted on either a spectrophotometer(Shimadzu PC160) or a microplate reader(Molecular Devices) . 3.Purification

Culture broth is filtered first on cheesecloth and centrifuged at 1000 x g to remove gelatinous pinkish xylidine polymer. The supernatant is then filtered on Whatman #2 paper and concentrated from 1500 to 250 ml on SlYlOO (Amicon, Spiral concentrator) at 4 ^* C. The concentrated broth is diluted with water until it reaches 0.8 mS(from 2.5 mS) and then concentrated on SlYlOO to 250 ml. The washed broth, thawed from -20'C freezing overnight, is subjected to Whatman #2 paper filtration to remove residual pinkish material, and then pH adjusted by NaOH from pH 6.1 to pH 7.7. This yellowish broth, 275 ml with 0.8 mS, is applied on a Q-Sepharose XK-26 column(-64 ml gel) equilibrated with 10 mM Tris-HCl, pH 7,7, 0.7 mS. The first active laccase fraction runs through during loading and washing by the equilibrating buffer. The elution is carried out by a linear gradient of 0-0.5 M NaCl in the equilibrating buffer over 8.8 bed-volume. The second and third active fractions are eluted around 0.15 and 0.35M NaCl, respectively. No more active fractions are detected when the column is washed sequentially with 2 M NaCl and with 1 mM NaOH. The active fractions are pooled, adjusted to ~10mS, concentrated on Centricon-10 (Amicon) , and then applied onto Superdex 75(HRlO/30, 24 ml, Pharmacia) equilibrated with lOmM Tris-HCl, 0.15 M NaCl, pH 8, 14 mS. During elution with the application buffer, laccase fractions are eluted off using the same elution volume for all three Q-Sepharose fractions, indicating very similar native molecular weight. The purity of the laccase is tested on SDS-PAGE. 4. Protein analysis

PAGE and native IEF are carried out on a Mini Protean II and a Model 111 Mini IEF cells (Bio-Rad) . Western blots are carried out on a Mini trans-blot cell (Bio-Rad) with an alkaline phosphatase assay kit (Bio-Rad) . The primary

antibodies are diluted 1000-fold during blotting. N- terminus sequencing is performed on an Applied Biosystems (ABI) 476A protein sequencer using liquid phase TFA delivery for cleavage and on-line HPLC for identification of PTH- amino acids. Standard Fast Cycles and Pre-Mix Buffer System is used according to manufacturer's instructions. Deglycosylation with glycosidase is done as follows: 3μg of protein and 3.6 units of glycosidase in 0.25M NaAc, pH 5, 20 mM EDTA, 0.05% 2-mercaptoethanol is incubated at 37°C for 18 hours with ovalbumin and bovine serum albumin serving as positive and negative control, respectively, and the mobility is detected by SDS-PAGE.

Amino acid analysis for determining extinction coefficients is done using Amino Quant 1090 HPLC system from Hewlett Packard. Microwave facilitated vapor phase hydrolysis of lyophilized samples is done using the MDS-2000 hydrolysis-station(CEM, Matthews, NC) . 6N HCl containing 1% phenol as a scavenger is used to create the acid vapors. Hydrolysis time is 20 minutes at 70 psi (-148 ^* C). Hydrolyzed samples are lyophilized and redissolved in 20 μl of 500pmol/μl sarcosine and norvaline as internal standards. lμl is injected and analyzed according to manufacturer's instructions. B. RESULTS AND DISCUSSION 1. Purification

The previously characterized P. pinsitus laccase has a pi of -3.5. However, considerable laccase activity is detected in the run-through fraction of Q-Sepharose pre- equilibrated at pH 7.7. Upon a gradient elution, one more active fraction comes off the column before the active fraction initially anticipated. UV-visible spectra and SDS- PAGE show that all three fractions contain mainly laccase. After further purification by gel filtration, different pi's under native non-denaturing conditions are detected for the

two new fractions and shown to be consistent with the elution order.

2. Characterization

The pure laccase preparations derived from Q-Sepharose eluates behave as a rather well-defined band on SDS-PAGE at -63 kDa. Deglycosylation detects -14% w/w carbohydrates based on mobility change on SDS-PAGE. On native-IEF, the laccase preparations have bands of pi 6-6.5, 5-6.5, and 3.5. ABTS-agarose overlay show that all bands are active. Each form in turn shows multiple isoforms under the IEF conditions.

The neutral and acidic forms have a typical UV-visible spectrum with maxima at 605 and 275 nm. The ratio of A ₂₇₅ A ₅₀₅ is 30-40. The spectrum for the acidic-neutral form has a peak at 276 nm and a shoulder around 600 nm.

The N-terminal sequencing shows that the neutral and neutral-acidic forms have the same first 29 residues(Table 1) . The N-terminus of the acidic form matches 100% to that of the previously characterized form. All three forms exhibit comparable cross-reactivity toward antibodies raised against previously characterized form.

Table 1. Structural and enzymatic properties of P. pinsitus laccases

Form N-terminus LACU AAi ₀₅ min-l (ABTS) Acidic GIGPVA D LTITNAAVSPDGFSRQAVWNG 92 4000

Acidic- A*****(*)*WA**P******L*D*I**** 75 4000 Neutral

Neutral A***** (*) * A**P******L*D*I**** 32 1000

*:Same residue as 'compared with the acidic form. (): weak signal

3. Laccase Activity

The specific activities (per A ₂ 7 ₅ ) of the three forms are tested by both ABTS and syringaldazine oxidations. The shapes and optima of the pH activity profiles for the three forms are very close: all have optima at <pH4 and pH 5-5.5 for ABTS and syringaldazine oxidations, respectively.

IV. ISOLATION OF MULTIPLE COPIES OF POLYPORUS PINSITUS LACCASE ENZYMES AND GENES

A. MATERIALS AND METHODS

1. Strains The following strains are employed in the methods described below: E. coli K802 (el4- (mrca) , mcrB, hsdR2, galK2, galT22, supE44, metBl; Clonetech) ; E. coli XL-1 Blue (recAl, endAl, gyrA96, thi-1, hsdRl7 , supE44, relAl, laciF'proAB, lacIqZDMl5, TnlO (tetr) ] ;Stratagene) and Polyporus pinsitus CBS 678.70. 2. Genomic DNA isolation Cultures of P. pinsitus are grown in 500 ml YG (0.5% yeast extract, 2% dextrose) at room temperature for 3 to 4 days. Mycelia are harvested through miracloth, washed twice with TE and frozen quickly in liquid nitrogen. The frozen mycelia are stored at -80'C. To isolate DNA, the mycelia

are ground to a fine powder in an electric coffee grinder. The powdered mycelia are resuspended in TE to a final volume of 22 ml. Four ml 20% SDS is added with mixing by inversion followed by incubation at room temperature for 10 minutes. The sample is gently extracted with phenol:chloroform and centrifuged to separate the phases. The aqueous phase is collected and 400μl proteinase A(10 mg/ml stock) is added. The sample is incubated at 37 ^* C for 30 minutes followed by a phenol:chloroform extraction. The aqueous phase is precipitated by the addition of 0.1 volumes of 3 M Na acetate, pH 5.2 and 2.5 volumes 95% ethanol and freezing at 20 ^* C for one hour. After centrifugation to precipitate the DNA, the pellet is resuspended in 6 ml TE, and 200 μl boiled R ase A(10 mg.ml stock) is added. After incubation at 37°C, 100 μl proteinase A(10 mg/ml stock) ^' is added followed by incubation at 37 ^* C for 30 minutes. The sample is phenol:chloroform extracted twice. To the aqueous phase, 0.1 volumes 3 M Na acetate and 2.5 volumes are added, and teh sample is frozen at -20'C for 1 hour. Following centrifugation, the pellet is gently resuspended in 400 μl TE, and 40 μl Na acetate and 1 ml 95% ethanol are added. The DNA is pelleted by centrifugation, and the pellet is washed in 70% ethanol. The final pellet is resuspended in 250 μl TE. 3. RNA preparation

RNA is isolated from mycelia which are harvested from P. pinisitus cultures which are either induced for laccase expression by the addition of 2,5-xylidine or are uninduced. The mycelia are washed and frozen quickly in liquid N ₂ . Frozen mycelia are ground to a fine powder in an electric coffee grinder. The powder is immediately suspended in 20 ml extraction buffer (0.2 M Tris-HCl, 0.25 M NaCl, 50 mM EGTA, 0.8% tri-isopropyl naphthalene sulfonic acids, 4.8% p- aminosalicylic acid, pH 8.5). All solutions for RNA

extraction are made with diethylpyrocarbonate (DEP) -treated water. The sample is kept on ice and 0.5 volumes TE- saturated phenol:chloroform is added. The sample is mixed well by inversion for 2 minutes, and the phases are separated by centrifugation. The aqueous phase is saved, and the organic phase is extracted with 2 ml extraction buffer and incubated at 68 'C for 5 minutes. After centrifugation to separate the phases, the aqueous phases are pooled and extracted several time with phenol:chloroform until there is no longer any protein at the interface. To the aqueous phase 0.1 volume 3 M Na-acetate, pH 5.2 and 2.5 volumes 95% ethanol are added to precipitate the RNA, and the sample is frozen at -20'C for 2 hours. The RNA is pelleted and resuspended in DEP water with RNase inhibitor. 4. DNA sequencing

Nucleotide sequences are determined using TAQ polymerase cycle sequencing with fluorescent-labeled nucleotides, and reactions are electrophoresed on an Applied Biosystems automatic DNA sequencer(Model 363A, version 1.2.0) .

5. Preparation of genomic libraries

Two size-selected genomic libraries of P. pinsitus are constructed. A library of 5 to 6 kb BamHI fragments are constructed in pBluescript+. Genomic DNA is digested with BamHI, and the digest is electrophoresed on a preparative agarose(IBI) gel. The region containing the 5 to 6 BamHI fragments is sliced from the gel. The DNA is isolated from teh gel using a Geneclean kit (BIO 101). The DNA is ligated into pBluescript plasmid previously digested with BamHI and dephosphorylated with BAP(GIBCO BRL) , E. coli XL-1 Blue competent cells (Stratagene) are transformed with the ligation, and 12,000 white colonies are obtained.

A library of 7 to 8 kb BamHI/EcoRI fragments is constructed in pUC118. Ten μg genomic DNA is digested with

BamHI and EcoRl and treated with BAP(GIBCO BRL) . Competent E. coli XL-1 Blue cells are transformed with the ligation, and the library contains -8000 recombinants.

For the preparation of a total genomic library in lambda EMBL4, 25 μg of P. pinsitus genomic DNA is partially digested with Sau3A. After digestion, the DNA is electrophoresed on a preparative low-melt agarose gel, and a band containing the 9 to 23 kb sized DNA is sliced from the gel. The DNA is extracted from the gel using β-agarose(New England Biolabs) . The isolated EMBL4 arms (Clonetech) according to the supplier's directions. The ligation. is packaged in vitro using a Gigapack II kit(Stratagene) . The library is titered using E. coli K802 cells. The unamplified library is estimated to contain 35,000 independent recombinants. The library is amplified using E. coli K802 cells.

6. Southern and Northern Blots

DNA samples are electrophoresed on agarose gels in TAE buffer using standard protocols. RNA samples are electrophoresed on agarose gels containing formaldehyde. Both DNA and RNA gels are transferred to Zeta-Probe membrane(BIO-RAD) using either capillary action under alkaline conditions or a vacuum blotter. After transfer, the DNA gels are UV crosslinked. Blots are prehybridized at 65'C in 1.5X SSPE, 1% SDS, 0.5% non-fat dried milk and 200 μg/ml salmon sperm DNA for 1 hour. Radioactive probes are added directly to the prehybridization solutions, and hybridizations are continued overnight at 65"C. Blots are washed with 2XSSC for 5 minutes at 65'C and with 0.2XSSC, 1%SDS,0.1% Na-pyrophosphate at 65'C for 30 minutes twice.

Radioactive labeled probes are prepared using a α- ³² P- dCTP and a nick translation kit(GIBCO-BRL) .

7. Library screening

For screening of the size-selected 5-6 kb BamHI and 7-8 kb BamHI/EcoRl libraries -500 colonies on LB carb plates and lifted the colonies to Hybond N ⁺ filters(Amersham) using standard procedures. The filters are UV crosslinked following neutralization. The filters are prehybridized at 65'C in 1,5X SSPE, 1% SDS, 0.5% non-fat dried milk, 200 μg/ml salmon sperm DNA for 1 hour. Nick-translated probes are added directly to the prehybridization solution, and hybridizations are done overnight at 65'C. For screening of the genomic bank in EMBL, appropriate dilutions of the amplified library are plated with E. coli K802 cells on lOO M NZY top agarose. The plaques are lifted to Hybond N ⁺ membranes(Amersham) using standard procedures. The DNA is crosslinked to the membranes using UV crosslinking. The filters are prehybridized and hybridized using the same conditions as those mentioned above. RESULTS AND DISCUSSION

1.Isolation of multiple copies of laccase gene P. pinsitus genomic DNA is digested with several different restriction enzymes for southern analysis. The blot is probed with the cDNA insert(isolated as a BamHi/Sphi fragment from the pYES vector) which is labeled with α-P ³² - dCTP. The blot is hybridized and washed as described above. The cDNA hybridizes to several restriction fragments for most of the enzymes suggesting that there are multiple laccase genes in the genome. Because the cDNA hybridizes to a BamHI fragment of -5.5 kb, a library of 5-6 kb BamHI fragments from P. pinisitus is constructed. 2. Screening of Genomic Libraries The results from screening of the libraries are summarized in Table 2. The 5-6 kb BamHI size-selected library is screened with the original cDNA clone labeled with ³² P. Approximately 30,000 colonies are screened with hybridizations done at 65'C. Plasmid DNA is isolated from

two positive colonies and digested with BamHI to check for insert size. Both clones contain an -5.5 kb BamHI insert. The cloned insert(LCC3) is sequenced from either end; the sequence has homology to the cDNA, but is clearly not the cDNA encoded laccase. The partial DNA sequence of LCC3 also indicates that the LCC3 pUCllδ clone does not contain the full gene.

From a southern blot of BamHl/EcoRl double digested DNA it is demonstrated that the cDNA hybridizes to an -7.7 kb fragment. A size-selected library in pUC118 is constructed containing 7-8 BamHI/EcoRI fragments. A total of -8000 independent colonies are obtained and screened by hybridization with a ³² P labeled insert. Plasmid DNA is isolated from the positive colonies and digested with BamHI and EcoRl. Restriction analysis of the plasmids demonstrate that they fall into two classes. One class (LCC4) contains four clones which are all identical and have an -7.7 kb BamHI/EcoRI insert which hybridizes to the cDNA. A second class(LCCl) contains two clones which are identical and have inserts of -7.2 kb which hybridize to the cDNA. Partial DNA sequencing of clones LCCl and LCC4 demonstrate that clone 21 is the genomic clone of the original cDNA, while LCC4 codes for another laccase. The partial DNA sequence of LCCl shows that the pUCllδ clone does not contain the full gene and that a fragment upstream of the EcoRl site is needed.

At the same time the size selected 7-8 BamHI/EcoRI library is being constructed, a P. pinisitus genomic bank in EMBL4 is constructed containing -35,000 independent recombinant phage. Ten positive plaques are picked and purified. DNA is isolated from the purified phage lysates. Restriction digests of EMBL DNAs demonstrates that there are three classes of clones. The first class(11GEN) is defined by two sibs whose inserts contain a BamHI/EcoRI fragment of the same size as LCCl which hybridizes to the LCCl insert.

The second class(12GEN) contains one clone which has a different restriction pattern than the 11GEN class and whose insert contains a different restriction pattern than the 11GEN class and whose insert contains an -5.7 kb BamHI/EcoRI fragment. The third class is defined by a single clone whose insert contains an -3.2 kb BamHI/EcoRI fragment which hybridizes to the LCCl insert. DNA sequence analysis demonstrates that clone 11GEN contains the LCCl BamHI/EcoRI fragment and both 5' and 3" flanking regions. It is also demonstrated that clone 12GEN contains a portion of the LCCl insert.

The P. pinisi tus EMBL genomic bank is also screened with the LCC3 BamHI insert in order to clone the full gene. Approximately 30,000 plaques are plated and lifted from hybridization. Five plaques which hybridize to the

LCC3 (BamHI/EcoRI) insert are identified and purified. DNA is isolated from the purified phage stocks. Southern analysis of P. pinisitus genomic DNA demonstrates that the LCC3 BAmHI insert hybridizes to an ~7kb EcoRl fragment. Restriction digests and southerns demonstrate that 4 of the clones contain restriction fragments which hybridize to the EcoRI/BamHI(1.6 kb) fragment and that the clones fall into three classes. Class one is defined by a single clone(LCC5) whose insert contains a 3kb EcoRl fragment which hybridizes to the LCC3 BamHI/EcoRI fragment. Another class is defined by clone(LCC2) whose insert contains an -11 kb EcoRl fragment which hybridizes to the LCC3 BamHI/EcoRI insert. The third class is defined by two clones which are not identical but contain many of the same restriction fragments; these clones both contain an -7.5 kb EcoRl fragment which hybridizes to the LCC3 insert. Further analysis of this third class indicates that they are identical to clone LCC4. Partial DNA sequencing of LCC5 and LCC2 indicates that both of these clones code for laccases;

however, neither is identical to any of the above mentioned laccase genes(LCCl, LCC3, or LCC4) . At this point, five unique laccase genes are cloned; however, the fragments subcloned from LCC5 and LCC2 do not contain the full genes. From the DNA sequencing of the 3 kb EcoRl fragment from clone LCC5 it is determined that -200 base pairs of the N- terminus are upstream of the EcoRl site. A 380 bp EcoRI/MluI fragment from LCC5 is used to identify for subcloning a Mlul fragment from the LCC5 EMBL clone. An -4.5 Mlul fragment from the LCC5 EMBL clone is subcloned for sequencing and shown to contain the N-terminal sequence.

To clone the N-terminal half of the LCC3 laccase gene, the P. pinsitus EMBL genomic bank is probed with an -750 bp BamHI/StuI restriction fragment from the LCC3 pUCllδ clone. Approximately 25,000 plaques are screened and five plaques appear to hybridize with the probe. Upon further purification only three of the clones are still positive. Two of the clones give very strong signals and the restrictions digests of DNA isolated from these phage demonstrate that both contain an -750 bp BamHI/StuI fragment in their inserts and that the two clones are not identical but overlapped. Based on results of Southern analysis, an -8.5 kb fragment from these clones are subcloned for sequencing. The EcoRl fragment is shown to contain the entire gene.

To clone the N-terminal half of the LCC2 laccase gene, the P. pinsitus genomic bank in EMBL4 is probed with an -680 bp EcoRI/PvuI of the EMBL LCC2 clone. Thirty thousand plaques are screened by hybridization at 65'C, and 15 plaques appear to hybridize with the probe. All fifteen are purified, and DNA is isolated. The clones can be placed in four classes based on restriction patterns, Seven of the clones are all sibs, and are identical to the original EMBL clone of LCC2. The second class is defined by 3 clones

which are sibs. An -4 kb Hindlll fragment is subcloned from this class for sequencing and is shown to contain the N- terminal half of LCC2. A third class is defined by a single clone and is not characterized further. 3. DNA sequencing

The complete DNA sequences of the five genomic clones is determined as described in Materials and Methods. Sequencing of clone LCC2 demonstrate that it probably codes for the second form of laccase(neutral pi) isolated from culture broth from an induced P. pinsitus culture as described above. The N-terminal protein sequence from the neutral pi laccase and the predicted N-terminus for the protein coded for by LCC2 are compared, and show identity. The predicted pi for the protein coded for by clone LCC2 is 5.95, which is in good agreement with the experimental pi determined for the second form of laccase being between 5.0 and 6.5. Figures 1-5 (SEQ ID NOS. 1-5) show the DNA sequences and predicted translation products for the genomic clones. For LCCl, the N-terminus of the mature protein as determined by protein sequencing and predicted by Von Heijne rules is Gly at position 22. The N-terminus is Gly-Ile-Gly- Pro-Val-Ala-. For LCC2 the N-terminal amino acid of the mature protein as determined by protein sequencing is Ala at position 21. The N-terminus is Ala-Ile-Gly-Pro-Val-Ala-. For LCC3 the predicted N-terminal amino acid of the mature protein is Ser at position 22, with the N terminus being Ser-Ile-Gly-Pro-Val-Thr-Glu-Leu-. For LCC4, the predicted N-terminal amino acid is Ala at position 23 with the N- terminuε being Ala-Ile-Gly-Pro-Val-Thr-. For LCC5 the predicted N-terminal amino acid is Ala at position 24 with the N-terminus being Ala-Ile-Gly-Pro-Val-Thr-Asp. A comparison of the structural organization of the genes and the predicted proteins they code for is presented in Table 1. It will be seen that the five genes have different

structural organizations and code for proteins of slightly different sizes. Comparisons between the predicted proteins of the genomic clones and other fungal laccase are also done. Table 2 shows a comparison of the predicted laccase to each other and to other fungal laccases. Clone LCCl(the induced laccase first characterized) has the most identity(90%) to the Coriolus hirsutus laccase and the PMl basidiomycete laccase(Coll et al., supra) . The other four laccases have between 64 and δ0% identity to the C. hirsutus laccase. The laccase coded for by LCC3 has the least identity to the LCCl laccase and the other fungal laccases shown in Table 2. LCC2 appears to be the second wild-type laccase isolated as described above; based on the N-terminal sequences of the isolated clones, it also appears that the "neutral" and acidic neutral" wild-type laccases are the same enzyme which is encoded by the LCC2 sequence.

Tablet Comparison of Structural Organization and Predicted Proteins of the P. pinsiiis Genomic Clone

Table Amino Acid Identity Between P. pinsitis Laccases and Other Fungal Laccases.

21GEN 23GEN 24GEN 31GEN 41GEN CRIPHA CRIPHE PBILAC P

21OEN, 23GEN, 24GEN, 31GENj_nd 41GEN= P. pinsitis laccase clones

CRIPHA= Coriol s hirsutis laccase A

CRIPHE= C. hirsutis laccase B

PBILAC= Phlebia radiata laccase

PM1= Basidiomycete PMl laccase (CECT2971)

5. Northern blots

RNA is isolated from mycelia from both a xylidine- induced culture and an uninduced culture. RNA is blotted to membrane after electrophoresis, and the blot is probed with the cDNA insert, or a small fragment containing -100 bp of the 23GEN promoter and the first 100 bp of the coding region. A transcript of about 1.8 kb hybridizes to both the induced and uninduced RNA samples; however, transcription of this message is clearly induced by the addition of xylidine to the culture.

III. EXPRESSION OF P. PINSITUS LACCASE IN ASPERGILLUS

MATERIALS AND METHODS

1. Strains

A. oryzae A1560, A. oryzae HowBl04 (fungamyl delete, pyrg) , A . oryzae HowBlOlpyrg, A. niger Bo-1, A. niger Bo-80, A. niger ATCC1040, A. niger NRRL337, A. niger NRRL326, A. niger NRRL326, A. niger NRRL2295, A . niger ATCC11358, A . niger NRRL322, A. niger AT10864, A. japonicus A1438, A. phoenicis, A. foetidus N953. 2. Media

For the shake flask cultivation of the A. niger, A. foetidus, and A. phoenicis MY50 (per liter:50 g maltodextrin, 2 g MgS0 ₄ -H ₂ 0, 10 gKH ₂ P0 ₄ , 2 g K ₂ S0 ₄ , 2 g citric acid, 10 g yeast extract, 0.5 ml trace metals, 2 g urea, pH 6.0) media is used. For the shake flask cultivation of the A. oryzae A1560 and HowBlOl strains MY51(per liter: 30 g maltodextrin, 2 mg MgS0 ₄ , 10 g KH ₂ P0 ₄ , 2 g K ₂ S0 ₄ , 2 g citric acid, 10 g yeast extract, 0.5 ml trace metals, 1 g urea, 2 g(NH ₄ ) S0 ₄ , pH 6.0) is used. For the shake flask analysis of the A. oryzae HowBl04 strains, MY51 maltose(same as MY51 but with 50g of maltose instead of maltodextrin) media is used. For the shake flask analysis of the A . japonicus strains M400 media(per liter: 50 g maltodextrin, 2 g MgS0 ₄ , 2 g

KH ₂ PO ₄ , 4 g citric acid, 8 g yeast extract, 0.5 ml trace metals, 2 g urea, pH 6.0.

Cultures grown overnight for protoplast formation and subsequent transformation are grown in YEG(0.5% yeast extract, 2% dextrose) . For strains that are pyrg, uridine is supplemented to 10 mM final concentration.

3. Screening for laccase production

Primary transformants are screened first on a minimal medium plates containing 1% glucose as the carbon source and ImM ABTS to test for production of laccase. Transformants that give green zones on the plates are picked and spore purified before shake flask analysis is done.

Shake flask samples are centrifuged to clear the broth. Dilute or undiluted broth samples are assayed with ABTS

RESULTS AND DISCUSSION

1. Expression in shake flasks

The first expression vector constructed is pDSYl, which contains the TAKA promoter, TAKA signal sequence, P. pinisitus laccase cDNA beginning at the mature N-terminus and the AMG terminator. The TAKA signal sequence: laccase insert is constructed in 2 steps. First by site directed mutagenesis, an Agel site beginning at bp 107 of the laccase mature coding region is created by a single base change and a Nsil site is created -120 bp downstream of the laccase Stop Cθdon(ACG GGT->ACC GGT and TTC GCT->ATG CAT, respectively) . A small PCR fragment beginning with an Sfil site and ending with the Agel site at 107 bp in laccase is PCR amplified. This fragment contains a piece of the TAKA signal sequence and the first -107 bp of the mature laccase cDNA. Further DNA sequencing of this fragment shows it has a single base change that leads to a substitution of Aεn for Thr at position 9 in mature laccase. This substitution creates a potential N-linked glycosylation site. The PCR

fragment and Agel/Nsil fragments are cloned into pM Rl(Figure 6) which has been digested with Sfil/Nsil. The vector pMWRl contains the TAKA promoter, a portion of the TAKA signal sequence which ends with an Sfil site, and the TAKA terminator with a Nsil site inserted directly 5' to the terminator. The resulting expression vector (Figure 7) is used to cotransform several hosts. Methods for co- transformation of Aspergillus strains are as described in Christensen et al., supra . In the second laccase expression vector, the base change in DSYl which leads to the substitution of Asn for Thr at amino acid 9 is reverted back to wild type by a PCR reaction. The second expression vector pDSY2 is identical to pDSYl except for this single base change. Three different A. oryzae strains and several A. niger strains are cotransformed with pDSY2 and either pTOC90( O 91/17243) which carries the A . nidulans amdS gene or pS02 which carries the A. oryzae pyrG gene.

Expression of laccase is observed in all hosts tested, with both DSYl and DSY2. Yields range from 0.1-12.0 Δabs/min/ml, with highest yields being observed with A. niger strains.

A construct pDSYlO is made which contains the TAKA promoter, laccase full-length cDNA including its own signal sequence and the AMG terminator. A 200 bp BamHI/Agel fragment which has a BamHI site immediately 5' to the ATG of the initiation codon and an Agel site at the same position as in pDSYl is PCR amplified using lacl as template. A Mlul/Hindlll fragment is PCR amplified using pDSY2 as template and begins with the Mlul site present in the cDNA and ends with a Hindu site directly 3 ' to the stop codon of laccase. The above two fragments and the Agel/Mlul fragment

from pDSY2 are ligated into pHD414 to yield pDSYlO(Figure 8) .

The vector pHD414 used in expression of laccase is a derivative of the plasmid p775(EP 238 023). In contrast to this plasmid, pHD414 has a string of unique restriction sites between the TAKA promoter and the AMG terminator. The plasmid is constructed by removal of an approximately 200 bp long fragment (containing undesirable RE sites) at the 3' end of the terminator, and subsequent removal of an approximately 250 bp long fragment at the 5' end of the promoter, also containing undesirable sites. The 200 bp region is removed by cleavage with Narl (positioned in the pUC vector) and Xbal (just 3' to the terminator), subsequent filling in the generated ends with Klenow DNA polymerase + dNTP, purification of the vector fragment on a gel and religation of the vector fragment. This plasmid is called pHD413. pHD413 is cut with StuI (positioned in the 5' end of the promoter) and PvuII (in the pUC vector) , fractionated on gel and religated, resulting in pHD414. Cotransformation of A. oryzae HowBl04 and A. niger Bo-1 are done using pToC90 for selection. Yields in shake flask are comparable to those seen with pDSY2.

2. Expression in fermentors

A 1 ml aliquot of a spore suspension of Aspergillus niger transformant Bo-l-pDSYlO-4 (approximately 10 ⁹ spores/ml) is added aseptically to a 500 ml shake flask containing 100 ml of sterile shake flask medium (glucose, 75g/l; soya meal, 20 g/1; MgS0 ₄ -7H ₂ 0, 2g/l; KH ₂ P0 ₄ , lOg/1; K ₂ S0 ₄ , 2g/l; CaCl ₂ -2H ₂ 0 0.5 g/1; Citric acid, 2g/l; yeast extract, lOg/1; trace metals[ZnS0 ₄ -7H ₂ 0, 14.3 g/1; CuS0 ₄ -5H ₂ 0, 2.5 g/1;

NiCl ₂ -6H ₂ 0, 0.5 g/1; FeS0 ₄ .7H ₂ 0, 13.8 g/1, MnS0 ₄ -H ₂ 0, 8.5 g/1; citric acid, 3.0 g/1], 0.5 ml/1; urea, 2g/l, made with tap water and adjusted to pH 6.0 before autoclaving), and incubated at 37'C on a rotary shaker at 200 rpm for 18

hours. 50 ml of this culture is aseptically transferred to a 3 liter fermentor containing 1.8 liters of the fermentor media (maltodextrin MD01 300 g/1; MgS0 ₄ -7H ₂ 0, 2g/l; KH ₂ P0 ₄ , 2g/l; citric acid 2g/l; K ₂ S0 ₄ , 2.7 g/l;CaCl ₂ -2H ₂ 0, 2g/l; trace metals, 0.5 ml/1; pluronic antifoam, lml/l; made with tap water and pH adjusted to 6.0 before autoclaving). The fermentor temperature is maintained at 34'C by the circulation of cooling water through the fermentor jacket. Sterile air is sparged through the fermentor at a rate of 1.8 liter/min (lv/v/m) . The agitation rate is maintained at 800 rpm for the first 24 hours after inoculation and at 1300 rpm for the remainder of the fermentation. The pH of the fermentation is kept at 4.0 by the automatic addition of 5N NaOH or H ₃ P0 ₄ . Sterile feed (urea, 50 g/1; pluronic antifoam, 1.5 ml/1, made up with distilled water and autoclaved) is added to the fermentor by use of a peristaltic pump. The feed rate profile during the fermentation is as follows: 40 g of feed is added initially before inoculation; after inoculation, feed is at a constant rate of 2.5 g/1 h. Copper is made as a 400X stock in water or a suitable buffer, filter sterilized and added aseptically to the tank to a final level of 0.5 mM. Samples for enzyme activity determination are withdrawn and filtered through Miracloth to remove mycelia. These samples are assayed for laccase activity by a LACU assay. Laccase activity is found to increase continuously during the course of the fermentation, with a value of approximately 55 LACU/ml is achieved after 190 hours. This corresponds to approximately 350mg/l of recombinant laccase expressed. IV. PURIFICATION OF RECOMBINANT LACCASE MATERIALS AND METHODS 1. Materials.

Chemicals used as buffers and substrates are commercial products of at least reagent grade. Endo/N-glycosidase G is

from Boehringer-Mannheim. Chromatography is performed on either a Pharmacia's FPLC or a conventional open column low pressure system. Spectroscopic assays are conducted on a Shimadzu PCI60 spectrophotometer. 2. Purification

(a) DSY2

2.8 liters cheese-cloth filtered brot (pH 7, 19mS) obtained from an A. oryzae pDSY2 transformant as described above is filtered on 0.45 μ Corning filter and concentrated on Spiral Concentrator(Amicon) with S1Y30 membrane to 200ml. The concentrate pH is adjusted to 7.5, diluted with 4.8 1 water to achieve 1.2 mS, and concentrated on S1Y30 to 200ml. 50ml of this broth solution is applied onto a Q-Sepharose column(XKl6, 34ml gel), pre-equilibrated with lOmM Tris, pH 7.5, 0.7 mS (Buffer A) . The blue laccase band that migrates slowly during loading is eluted by a linear gradient of Buffer B(Buffer A plus 0.5 M NaCl) . 24 ml of pooled laccase fractions are concentrated on Centricon-100 (Amicon) to 4.5 ml and applied onto a Superdex 200 column(HiLoad 16/60, 120 ml gel). During the development with Buffer C(Buffer A plus 0.15 M NaCl, 14.4 mS) , the blue laccase fractions elute followed by brownish contaminant fractions. Only the first half of the elution band(detected by Abs ₆ oo) show a high laccase to contaminant ratio and are pooled. The pooled fractions are dialyzed in lOmM Bis-Tris, pH 6.8,

0.6mS (Buffer D) , applied onto a Mono-Q column(Mono-Q 5/5, lml) equilibrated with Buffer D, and eluted with Buffer E(Bufer D plus 0.5 M NaCl) using a linear gradient. The laccase fractions, which ome out round 27% Buffer E, are pure as judged by SDS-PAGE. At each step, the laccase fractions are routinely checked by ABTS oxidation, SDS-PAGE, and Western Blot.

(b) DSY10

2.8 liters cheese-cloth filtered broth(pH 7.3, 24mS) obtained from HowBl04-pDSYlO is filtered on Whatman #2 paper and concentrated on Spiral Concentrator(Amicon) with SlYlOO membrane to 210ml. The concentrate pH is diluted with water to achieve 1.2 mS, and concentrated on SlYlOO to 328 ml. This broth solution is applied onto a Q-Sepharose column(XK26, 120 ml gel), pre-equilibrated with lOmM Tris, pH 7.5, 0.7 mS(Buffer A). The blue laccase band that migrates slowly during loading is eluted by a linear gradient of Buffer B(Buffer A plus 2 M NaCl) . 120 ml of pooled laccase fractions are diluted with water to achieve l.lmS and then concentrated on SIY100 to 294 ml and applied onto a Mono-Q column(HiLoad 16/10, 40 ml gel) pre- equilibrated with Buffer A. The laccase slowly passes through the column during loading and washing with Buffer A. The pooled fractions which have a pH reading of 5.6, are loaded on a Mono-Q column(HiLoad 16/10, 40 ml gel), pre- equilibrated with Buffer CdOmM MES, pH 5.5, 0.1 mS) . The laccase fractions elute by a very shallow gradient of Buffer D(Buffer C + 1M NaCl) . Enzymatic assays are conducted as described above.

3. Protein analysis

Total amino acid analysis, N-terminal sequencing, deglycosylation, SDS-PAGE, IEF, and Western blots are performed as decribed above. B. RESULTS AND DISCUSSION

1. Purification and Characterization

Overall a 256-fold purification and a yield of 37% are achieved for DSY10, and a 246-fold purification and a yield of 14% are achieved for DSY2 In terms of electorphoretic pattern, spectral properties and activity, purified DSY2 and DSY10 are indistinguishable. Purified recombinant laccases behave as a dimer on gel filtration, and exhibit subunit molecular weight which is somewhat larger than that of the

wild type laccase, indicating a post-translational processing in A. oryzae that results in the extra glycosylation on the recombinants. Deglycosylation has confirmed the difference in mass arising from extra sugars(Table 3).

Table 3.Molecular and spectral properties of recombinant and wild-type laccase

pi λ _max ,nm(ε,l/g*cm)

3.5 275(1.8)615(0.12) 3.5 275(1.7)615(0.11)

The spectra of the purified laccases have maxima of 615 nm and 275, with the ratio of absorbance at 275 nm to that at 615 nm being 16, indicating one Type I Cu per subunit. The ratio of absorbance at 330nm to that at 615nm is 1.0, close to the 0.75 value of Rhus vernicefera laccase, suggesting the presence of one Type II and two Type III copper ions per subunit. The extinction coefficient determined by amino acid analysis is 1.71/(g*cm), 3. Activity The laccase activity is measured by syringaldazine and ABTS oxidations. Expressed per A ₂₇₅ , the laccase has a value of 83 for LACU. Expressed per mg, it has a LACU of 141. The pH profile of the laccase is provided in Figure 9.

V. USE OF POLYPORUS LACCASE TO DYE HAIR

The dyeing effect of Polyporus pinsitus laccase is tested and compared to the dyeing effect of 3% H ₂ 0 ₂ on various dye precursors (listed below) and further on 0.1% p- phenylenediamine compared with a number of modifiers.

Materials :

Dye precursors:

0.1 % p-phenylene-diamine in 0.1 M K-phosphate buffer, pH

7.0. (pPD)

0.1 % p-toluylene-diamine in 0.1 M K-phosphate buffer, pH 7.0.

0.1 % chloro-p-phenylenediamine in 0.1 M K-phosphate buffer, pH 7.0. 0.1 % p-aminophenol in 0.1 M K-phosphate buffer, pH 7.0. 0.1 % o-aminophenol in 0.1 M K-phosphate buffer, pH 7.0. 0.1 % 3,4-diaminotoluene in 0.1 M K-phosphate, buffer pH 7.0.

Modifiers:

0.1 % m-phenylene-diamine in 0.1 M K-phosphate buffer, pH

7.0.

0.1 % 2,4-diaminoanisole in 0,1 M K-phosphate buffer, pH

7.0. 0.1 % α-naphthol in 0.1 M K-phosphate buffer, pH 7.0.

0.1 % hydroquinone in 0.1 M K-phosphate buffer, pH 7.0. 0.1 % pyrocatechol in 0.1 M K-phosphate buffer, pH 7.0. 0.1% resorcinol in 0.1 M K-phosphate buffer, pH 7.0. 0.1 % 4-chlororesorcinol in 0.1 M K-phosphate buffer, pH 7.0.

When a modifier is used, the dye precursor p-phenylene- diamine is combined with one of the above indicated modifiers so that the final concentration in the dyeing solution is 0.1 % with respect to precursor and 0.1 % with respect to modifier. The enzyme used is a recombinant laccase from Polyporus pinisitus, at a concentration of 10 LACU/ml.

Other solutions used in the process are 3% H ₂ 0 ₂ (in the final dye solution), and a commercial shampoo.

The quantitative color of the hair tresses is deter¬ mined on a Datacolor Textflash 2000 (CIE-Lab) by the use of

CIE-Lab parameters L* ("0"=black and "100"=white) combined with a* ("-"=green and "+"=red). DL* and Da* are the delta values of L* and a*, respectively, of a sample when compared to L* and a* of untreated hair. The Light fastness is determined under a day light bulb (D65) at 1000 LUX.

Hair tresses of blond European hair (1 gram) are used. 4 ml dye precursor solution (including modifier)is mixed with 1 ml laccase or 1 ml Hθ ₂ on a Whirley mixer, applied to the hair tresses and kept at 30°C for 60 minutes. The hair tresses are then rinsed with running water, combed, and air dried.

The results of the dyeing effect test are displayed below in Table 4-6 and further in the graphs in Figures 10 to 12.

Table 4

0=black, 100= hite a*: -=green, +=red

Table 5

L*: 0=black, 100= hite -=green, +=red

Table 6

L*: 0=black, 100=white -=green, +=red

The oxidative hair dyeing is carried out as described above, except that 50 LACU/ml Polyporus pinsi tus laccase was used.

To test wash stability, the dyed hair tresses are wetted and washed for 15 seconds with 50 μl of commercial shampoo, and rinsed with water for 1 minute. The hair tresses are washed up to 20 times.

The results of the hair wash test are displayed in figure 13. It can be seen in figure 13 that the wash stability of hair washed up to 20 times is excellent, when using Polyporus pinsitus laccase for oxidative dyeing.

To test light fastness, tresses of blond european hair are used for testing the light fastness of hair dyed using Polyporus pinsitus laccase in comparison to hair dyed using H ₂ O ₂ . p-phenylene-diamine is the dye precursor. The dyeing of the hair is carried out as described above. One hair tress is kept dark, while an other is kept at day light (i.e. under a day light bulb (D65)), at approximately 1000 LUX) for up to 275 hours. The CIE-Lab-values are determined immediately after the dyeing of the hair, and further during exposure to day light.

The results of the test are displayed in figure 14. Figure 14 shows that the hair dyed with p-phenylene-diamine using Polyporus pinsitus laccase has the same light fastness as hair dyed using H ₂ 0 ₂ .

Deposit of Biological Materials

The following biological materials have been deposited under the terms of the Budapest Treaty with the Agricultural Research Service Patent Culture Collection, Northern

Regional Research Center, 1815 University Street, Peoria,

Illinois, 61604 on May 25, 1994 and given the following accession numbers.

Deposit Accession Number

E. coli DH5α containing NRRL B-21263 pDSY22(41GEN; an -3.0 kb EcoRI insert) E. coli DH5α containing NRRL B-21268

PDSY23 (41GEN; an -4.5 kb Mlul insert; insert contains a small portion of the

EcoRI fragment of pDSY22 and sequences 5' to the EcoRI fragment)

E. coli XL-1 Blue containing NRRL B-21264

PDSY2K31GEN; an -7.7 kb EcoRI/BamHI insert)

E. coli XL-1 Blue containing NRRL B-21265 pDSYl8(21GEN; an -8.0 kb BamHI insert)

E. coli DH5oc containing NRRL B-21266 pDSYl9(23GEN; an -4 kb Hindlll insert)

E. coli DH5α containing NRRL B-21267 pDSY20(24GEN; an -8.5 kb EcoRI insert)

SEQUENCE LISTING

(1) GENERAL INFORMATION:

(i) APPLICANT:

(A) NAME: Novo Nordisk Biotech, Inc.

(B) STREET: 1445 Drew Avenue

(C) CITY: Davis, California

(D) COUNTRY: United States of America

(E) POSTAL CODE (ZIP) : 95616-4880

(F) TELEPHONE: (916) 757-8100

(G) TELEFAX: (916) 758-0317

(i) APPLICANT:

(A) NAME: Novo Nordisk A/S

(B) STREET: NOVO Alle

(C) CITY: Bagsvard

(D) COUNTRY: Denmark

(E) POSTAL CODE (ZIP) : DK-2880

(F) TELEPHONE: +45.4444 8888

(G) TELEFAX: +45 4449 3256 (F) TELEX: 37304

(ii) TITLE OF INVENTION: PURIFIED POLYPORUS LACCASES AND

NUCLEIC ACIDS ENCODING SAME

(iii) NUMBER OF SEQUENCES: 10

(iv) CORRESPONDENCE ADDRESS:

(A) ADDRESSEE: Novo Nordisk of North America, Inc.

(B) STREET: 405 Lexington Avenue, Suite 6400

(C) CITY and STATE: New York, New York

(D) COUNTRY: U.S.A.

(E) ZIP: 10174-6401

(v) COMPUTER READABLE FORM:

(A) MEDIUM TYPE: Floppy disk

(B) COMPUTER: IBM PC compatible

(C) OPERATING SYSTEM: PC-DOS/MS-DOS

(D) SOFTWARE: Patentln Release #1.0, Version #1.25 (EPO)

(vi) CURRENT APPLICATION DATA:

(A) APPLICATION NUMBER: Co be assigned

(B) FILING DATE: 15-June-1995

(vii) PRIOR APPLICATION DATA:

(A) APPLICATION NUMBER: 08/265,534

(B) FILING DATE: 24-June-1994

(viii) ATTORNEY/AGENT INFORMATION:

(A) NAME: Lowney, Karen A.

(B) REGISTRATION NUMBER: 31,274

(C) REFERENCE/DOCKET NUMBER: 4185.204-WO

(ix) TELECOMMUNICATION INFORMATION:

(A) TELEPHONE: 212 867 0123

(B) TELEFAX: 212 878 9655

(2) INFORMATION FOR SEQ ID NO: 1:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 2418 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: double

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: DNA (genomic)

(vi) ORIGINAL SOURCE:

(A) ORGANISM: Polyporus pinsitus

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 414..464

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 534..589

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 710..764

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 879..934

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1001..1050

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1147..1197

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1354..1410

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1609..1662

(ix) FEATURE:

(A) NAME/KEY: CDS

(B) LOCATION: join (413..465, 533..590, 709..765, 878..935,

1000..1051, 1146..1198, 1353..1411, 1608..1663)

(Xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1:

AGATTTCTGA CACCGGTGCA ATCTTGACAC TGTACCAACC GGGCAAGTCT CGTCCTTGGT 60

TCTCGGGGACT GGCGCCGGT CGCTACCCCT TGGTCATTCA CTCTACCAGA GCGCTGGCTT 120

CGCCGAGGTA TAAAGGATGT TGCGCGACAC CCTCAACACC CCAACTCAAG CCCCACTTGA 180

GCTTTTGCGA GATCCTCCAC ATACCACTCA CTACTTTCAA GTTCTTCAAC ATG TCG AGG 239

Met Ser Arg 1

TTT CAC TCT CTT CTC GCT TTC GTC GTT GCT TCC CTT ACG GCT GTG GCC 287

Phe His Ser Leu Leu Ala Phe Val Val Ala Ser Leu Thr Ala Val Ala 5 10 15

CAC GCT GGT ATC GGT CCC GTC GCC GAC CTA ACC ATC ACC AAC GCA GCG 335

His Ala Gly He Gly Pro Val Ala Asp Leu Thr He Thr Asn Ala Ala 20 25 30 35

GTC AGC CCC GAC GGG TTT TCT CGC CAG GCC GTC GTC GTG AAC GGC GGC 383

Val Ser Pro Asp Gly Phe Ser Arg Gin Ala Val Val Val Asn Gly Gly 35 40 45

ACC CCT GGC CCT CTC ATC ACG GGT AAC ATG GTTCGTCTCG GCTCGCACTA 433

Thr Pro Gly Pro Leu He Thr Gly Asn Met 50 55

GGGGGTTGTA TCGTTCCTGA CGTTGTTGGA G GGG GAT CGC TTC CAG CTC AAT GTC ATC 491

Gly Asp Arg Phe Gin Leu Asn Val He 60 65

GAC AAC CTT ACC AAC CAC ACG ATG GTG AAG AGC ACG AGT ATT GTGAGCTGCT 543 Asp Asn Leu Thr Asn His Thr Met Val Lys Ser Thr Ser He 70 75

ATTTCTCCGG ACGGGGCTTC ATTGTGCTAA TAATCGTCGT GTGCAG CAC TGG CAC GGT 601

His Trp His Gly 80

TTC TTC CAG AAG GGT ACC AAC TGG GCC GAC GGT CCC GCC TTC ATC AAC 649

Phe Phe Gin Lys Gly Thr Asn Trp Ala Asp Gly Pro Ala Phe He Asn 85 90 95

CAG TGC CCG ATC TCA TCT GGT CAC TCG TTC CTG TAC GAC TTC CAG GTT 697

Gin Cys Pro He Ser Ser Gly His Ser Phe Leu Tyr Asp Phe Gin Val 100 105 110 115

CCT GAC CAG GCT GTAAGTACGG TCGTTATGGA GTATACTGCG CATTGCTAAA 749

Pro Asp Gin Ala

CCACATGGTG AACAG GGT ACC TTC TGG TAT CAC AGT CAC TTG TCT ACG CAG 800 Gly Thr Phe Trp Tyr His Ser His Leu Ser Thr Gin 120 125 130

TAC TGT GAT GGT TTG AGG GGT CCG TTC GTT GTT TAC GAC CCG AAT GAC 848

Tyr Cys Asp Gly Leu Arg Gly Pro Phe Val Val Tyr Asp Pro Asn Asp 135 140 145

CCG GCC GCC GAC CTG TAC GAC GTC GAC AAC GTAAGGACGA ATTCGAACCG 898

Pro Ala Ala Asp Leu Tyr Asp Val Asp Asn 150 155

TAAATACTTG CTTACTGATA CTTCTCGATG AATTAG GAC GAC ACT GTC ATT 949

Asp Asp Thr Val He 160

ACC CTT GTG GAT TGG TAC CAC GTC GCC GCG AAG CTG GGC CCC GCA TTC 997

Thr Leu Val Asp Trp Tyr His Val Ala Ala Lys Leu Gly Pro Ala Phe 165 170 175

CCT GTAAGTCCAT GAGTATTCTG CTGTTGAATC TGTCTTAACT GTGCATATCA CTC 1053

Pro Leu

180

GGC GCC GAC GCC ACC CTC ATC AAC GGT AAG GGA CGC TCC CCC AGC ACG 1101 Gly Ala Asp Ala Thr Leu He Asn Gly Lys Gly Arg Ser Pro Ser Thr 185 190 195

ACC ACC GCG GAC CTC TCA GTT ATC AGC GTC ACC CCG GGT AAA CGC 1146

Thr Thr Ala Asp Leu Ser Val He Ser Val Thr Pro Gly Lys Arg 200 205 210

GTATGCTATA TCTTATCTTA TCTGATGGCA TTTCTCTGAG ACATTCTCCA G 1197

TAC CGT TTC CGC CTG GTG TCC CTG TCG TGC GAC CCC AAC TAC ACG TTC 1245 Tyr Arg Phe Arg Leu Val Ser Leu Ser Cys Asp Pro Asn Tyr Thr Phe 215 220 225

AGC ATC GAT GGT CAC AAC ATG ACG ATC ATC GAG ACC GAC TCA ATC AAC 1293 Ser He Asp Gly His Asn Met Thr He He Glu Thr Asp Ser He Asn 230 235 240

ACG GCG CCC CTC GTC GTC GAC TCC ATT CAG ATC TTC GCC GCC CAG CGT 1341 Thr Ala Pro Leu Val Val Asp Ser He Gin He Phe Ala Ala Gin Arg 245 250 255

TAC TCC TTC GTG GTAAGTTCGA TTCATCCTCT AACGTTGGTC GCTGTTAGTG 1393

Tyr Ser Phe Val 260

ATCGTATGGT CATGTAG CTC GAG GCC AAC CAG GCC GTC GAC AAC TAC TGG 1443 Leu Glu Ala Asn Gin Ala Val Asp Asn Tyr Trp 265 270

ATT CGC GCC AAC CCG AAC TTC GGT AAC GTC GGG TTC ACC GGC GGC ATT 1491 He Arg Ala Asn Pro Asn Phe Gly Asn Val Gly Phe Thr Gly Gly He 275 280 285 290

AAC TCG GCT ATC CTC CGC TAC GAT GGT GCC GCT GCC GTG GAG CCC ACC 1539 Asn Ser Ala He Leu Arg Tyr Asp Gly Ala Ala Ala Val Glu Pro Thr 295 300 305

ACA ACG CAA ACC ACG TCG ACT GCG CCG CTC AAC GAG GTC AAC CTG CAC 1587 Thr Thr Gin Thr Thr Ser Thr Ala Pro Leu Asn Glu Val Asn Leu His 310 315 320

CCG CTG GTT ACC ACC GCT GTG GTATGTAATA TTGTCGGTAA TGTAATACAT 1638 Pro Leu Val Thr Thr Ala Val 325

TGTTGCTGAC CTCGACCCCC ACAG CCT GGC TCG CCC GTC GCT GGT GGT GTC 1689

Pro Gly Ser Pro Val Ala Gly Gly Val 330 335

GAC CTG GCC ATC AAC ATG GCG TTC AAC TTC AAC GGC ACC AAC TTC TTC 1737 Asp Leu Ala He Asn Met Ala Phe Asn Phe Asn Gly Thr Asn Phe Phe 340 345 350

ATC AAC GGC ACG TCT TTC ACG CCC CCG ACC GTG CCT GTC CTG CTC CAG 1785 He Asn Gly Thr Ser Phe Thr Pro Pro Thr Val Pro Val Leu Leu Gin 355 360 365 370

ATC ATC AGC GGC GCG CAG AAC GCG CAG GAC CTC CTG CCC TCC GGT AGC 1833 He He Ser Gly Ala Gin Asn Ala Gin Asp Leu Leu Pro Ser Gly Ser 375 380 385

GTC TAC TCG CTT CCC TCG AAC GCC GAC ATC GAG ATC TCC TTC CCC GCC 1881 Val Tyr Ser Leu Pro Ser Asn Ala Asp He Glu He Ser Phe Pro Ala 390 395 400

ACC GCC GCC GCC CCC GGT GCG CCC CAC CCC TTC CAC TTG CAC GGG CAC 1929 Thr Ala Ala Ala Pro Gly Ala Pro His Pro Phe His Leu His Gly His 405 410 415

GCG TTC GCG GTC GTC CGC AGC GCC GGC AGC ACG GTT TAC AAC TAC GAC 1977 Ala Phe Ala Val Val Arg Ser Ala Gly Ser Thr Val Tyr Asn Tyr Asp 420 425 430

AAC CCC ATC TTC CGC GAC GTC GTC AGC ACG GGG ACG CCT GCG GCC GGT 2025 Asn Pro He Phe Arg Asp Val Val Ser Thr Gly Thr Pro Ala Ala Gly 435 440 445 450

GAC AAC GTC ACC ATC CGC TTC CGC ACC GAC AAC CCC GGC CCG TGG TTC 2073 Asp Asn Val Thr He Arg Phe Arg Thr Asp Asn Pro Gly Pro Trp Phe 455 460 465

CTC CAC TGC CAC ATC GAC TTC CAC CTC GAG GCC GGC TTC GCC GTC GTG 2121 Leu His Cys His He Asp Phe His Leu Glu Ala Gly Phe Ala Val Val 470 475 480

TTC GCG GAG GAC ATC CCC GAC GTC GCG TCG GCG AAC CCC GTC CCC CAG 2169 Phe Ala Glu Asp He Pro Asp Val Ala Ser Ala Asn Pro Val Pro Gin 485 490 495

GCG TGG TCC GAC CTC TGT CCG ACC TAC GAC GCG CTC GAC CCG AGC GAC 2217

Ala Trp Ser Asp Leu Cys Pro Thr Tyr Asp Ala Leu Asp Pro Ser Asp 500 505 510

CAG TAAATGGCTT GCGCCGGTCG ATGATAGGAT ATGGACGGTG AGTTCGCACT 2270

Gin

515

TGCAATACGG ACTCTCGCCT CATTATGGTT ACACACTCGC TCTGGATCTC TCGCCTGTCG 2330

ACAGAACAAA CTTGTATAAT TCGCTTAATG GTTGAAACAA ATGGAATATT GGGGTACTAT 2390

GCACGCATCT CGCTGGGTGA GCTTTCGT 2418

(2) INFORMATION FOR SEQ ID NO: 2:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 520 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

( i) ORIGINAL SOURCE:

(A) ORGANISM: Polyporus pinsitus

(Xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2:

Met Ser Arg Phe His Ser Leu Leu Ala Phe Val Val Ala Ser Leu Thr 1 5 10 15

Ala Val Ala His Ala Gly He Gly Pro Val Ala Asp Leu Thr He Thr 20 25 30

Asn Ala Ala Val Ser Pro Asp Gly Phe Ser Arg Gin Ala Val Val Val 35 40 45

Asn Gly Gly Thr Pro Gly Pro Leu He Thr Gly Asn Met Gly Asp Arg 50 55 60

Phe Gin Leu Asn Val He Asp Asn Leu Thr Asn His Thr Met Val Lys 65 70 75 80

Ser Thr Ser He His Trp His Gly Phe Phe Gin Lys Gly Thr Asn Trp 85 90 95

Ala Asp Gly Pro Ala Phe He Asn Gin Cys Pro He Ser Ser Gly His 100 105 110

Ser Phe Leu Tyr Asp Phe Gin Val Pro Asp Gin Ala Gly Thr Phe Trp 115 120 125

Tyr His Ser His Leu Ser Thr Gin Tyr Cys Asp Gly Leu Arg Gly Pro 130 135 140

Phe Val Val Tyr Asp Pro Asn Asp Pro Ala Ala Asp Leu Tyr Asp Val 145 150 155 160

Asp Asn Asp Asp Thr Val He Thr Leu Val Asp Trp Tyr His Val Ala 165 170 175

Ala Lys Leu Gly Pro Ala Phe Pro Leu Gly Ala Asp Ala Thr Leu He 180 185 190

Asn Gly Lys Gly Arg Ser Pro Ser Thr Thr Thr Ala Asp Leu Ser Val 195 200 205

He Ser Val Thr Pro Gly Lys Arg Tyr Arg Phe Arg Leu Val Ser Leu

210 215 220

Ser Cys Asp Pro Asn Tyr Thr Phe Ser He Asp Gly His Asn Met Thr 225 230 235 240

He He Glu Thr Asp Ser He Asn Thr Ala Pro Leu Val Val Asp Ser 245 250 255

He Gin He Phe Ala Ala Gin Arg Tyr Ser Phe Val Leu Glu Ala Asn 260 265 270

Gin Ala Val Asp Asn Tyr Trp He Arg Ala Asn Pro Asn Phe Gly Asn 275 280 285

Val Gly Phe Thr Gly Gly He Asn Ser Ala He Leu Arg Tyr Asp Gly 290 295 300

Ala Ala Ala Val Glu Pro Thr Thr Thr Gin Thr Thr Ser Thr Ala Pro 305 310 315 320

Leu Asn Glu Val Asn Leu His Pro Leu Val Thr Thr Ala Val Pro Gly 325 330 335

Ser Pro Val Ala Gly Gly Val Asp Leu Ala He Asn Met Ala Phe Asn 340 345 350

Phe Asn Gly Thr Asn Phe Phe He Asn Gly Thr Ser Phe Thr Pro Pro 355 360 365

Thr Val Pro Val Leu Leu Gin He He Ser Gly Ala Gin Asn Ala Gin 370 375 380

Asp Leu Leu Pro Ser Gly Ser Val Tyr Ser Leu Pro Ser Asn Ala Asp 385 390 395 400

He Glu He Ser Phe Pro Ala Thr Ala Ala Ala Pro Gly Ala Pro His 405 410 415

Pro Phe His Leu His Gly His Ala Phe Ala Val Val Arg Ser Ala Gly 420 425 430

Ser Thr Val Tyr Asn Tyr Asp Asn Pro He Phe Arg Asp Val Val Ser 435 440 445

Thr Gly Thr Pro Ala Ala Gly Asp Asn Val Thr He Arg Phe Arg Thr 450 455 460

Asp Asn Pro Gly Pro Trp Phe Leu His Cys His He Asp Phe His Leu 465 470 475 480

Glu Ala Gly Phe Ala Val Val Phe Ala Glu Asp He Pro Asp Val Ala 485 490 495

Ser Ala Asn Pro Val Pro Gin Ala Trp Ser Asp Leu Cys Pro Thr Tyr 500 505 510

Asp Ala Leu Asp Pro Ser Asp Gin 515 520

(2) INFORMATION FOR SEQ ID NO:3:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 2880 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION : 544 . . 592

( ix ) FEATURE :

(A) NAME/KEY: intron

(B) LOCATION: 837..899

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1014..1066

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1133..1187

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1284..1342

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1752..1815

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1873..1928

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 2136..2195

(ix) FEATURE:

(A) NAME/KEY: CDS

(B) LOCATION: join(364..543, 593..661, 716..835, 900..1013,

1067..1132, 1188..1283, 1343..1498, 1554..1751, 1816..1872, 1929..2135, 2196..2489)

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 662..715

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1499..1553

( i) SEQUENCE DESCRIPTION: SEQ ID NO:3:

GCGGCGCACA AACCGTGGGA GCCAACACAC TCCCGTCCAC TCTCACACTG GCCAGATTCG 60

CGCGACCGCC GCCTTTCAGG CCCAAACAGA TCTGGCAGGT TTCGATGGCG CACGCCGCCG 120

TGCCTGCCGG ATTCAATTGT GCGCCAGTCG GGCATCCGGA TGGCTCTACC AGCGCGGTTG 180

ACTGGAAGAG AACACCGAGG TCATGCATTC TGGCCAAGTG CGGCCAAAGG ACCGCTCGCT 240

GGTGCGGATA CTTAAAGGGC GGCGCGGGGA GGCCTGTCTA CCAAGCTCAA GCTCGCCTTG 300

GGTTCCCAGT CTCCGCCACC CTCCTCTTCC CCCACACAGT CGCTCCATAG CACCGTCGGC 360

GCC ATG GGT CTG CAG CGA TTC AGC TTC TTC GTC ACC CTC GCG CTC GTC 408 Met Gly Leu Gin Arg Phe Ser Phe Phe Val Thr Leu Ala Leu Val 1 5 10 15

GCT CGC TCT CTT GCA GCC ATC GGG CCG GTG GCG AGC CTC GTC GTC GCG 456 Ala Arg Ser Leu Ala Ala He Gly Pro Val Ala Ser Leu Val Val Ala 20 25 30

AAC GCC CCC GTC TCG CCC GAC GGC TTC CTT CGG GAT GCC ATC GTG GTC 504 Asn Ala Pro Val Ser Pro Asp Gly Phe Leu Arg Asp Ala He Val Val 35 40 45

AAC GGC GTG GTC CCT TCC CCG CTC ATC ACC GGG AAG AAG GTCGGCGTGT 553 Asn Gly Val Val Pro Ser Pro Leu He Thr Gly Lys Lys 50 55 60

TCGTCGTCGT CCTACTCCTT TGCTGACAGC GATCTACAG GGA GAC CGC TTC CAG 607

Gly Asp Arg Phe Gin 65

CTC AAC GTC GTC GAC ACC TTG ACC AAC CAC AGC ATG CTC AAG TCC ACT 655 Leu Asn Val Val Asp Thr Leu Thr Asn His Ser Met Leu Lys Ser Thr 70 75 80

AGT ATC GTAAGTGTGA CGATCCGAAT GTGACATCAA TCGGGGCTAA TTAACCGCGC 711 Ser He

ACAG CAC TGG CAC GGC TTC TTC CAG GCA GGC ACC AAC TGG GCA GAA GGA 760 His Trp His Gly Phe Phe Gin Ala Gly Thr Asn Trp Ala Glu Gly 85 90 95

CCC GCG TTC GTC AAC CAG TGC CCT ATT GCT TCC GGG CAT TCA TTC CTG 808 Pro Ala Phe Val Asn Gin Cys Pro He Ala Ser Gly His Ser Phe Leu 100 105 110

TAC GAC TTC CAT GTG CCC GAC CAG GCA GTAAGCAGGA TTTTCTGGGG 855

Tyr Asp Phe His Val Pro Asp Gin Ala 115 120

TCCCCGTGTG ATGCAATGTT CTCATGCTCC GACGTGATCG ACAG GGG ACG TTC TGG 911

Gly Thr Phe Trp 125

TAC CAC AGT CAT CTG TCT ACG CAG TAC TGT GAC GGG CTG CGG GGG CCG 959 Tyr His Ser His Leu Ser Thr Gin Tyr Cys Asp Gly Leu Arg Gly Pro 130 135 140

TTC GTC GTG TAC GAC CCC AAG GAC CCG CAC GCC AGC CGT TAC GAT GTT 1007 Phe Val Val Tyr Asp Pro Lys Asp Pro His Ala Ser Arg Tyr Asp Val 145 150 155

GAC AAT GTACGTGCGC CACGGAGTAT ATCACACAGC ATGCGTTGAC GTCGGGCCAA 1063

Asp Asn

160

CAG GAG AGC ACG GTC ATC ACG TTG ACC GAC TGG TAC CAC ACC GCT GCC 1111 Glu Ser Thr Val He Thr Leu Thr Asp Trp Tyr His Thr Ala Ala 165 170 175

CGG CTC GGT CCC AAG TTC CCA GTAAGCTCGC AATGGCTTAG TGTTCACAGG 1162 Arg Leu Gly Pro Lys Phe Pro 180

TTCTTTGCTT ATGTTGCTTC GATAG CTC GGC GCG GAC GCC ACG CTC ATC AAC 1214

Leu Gly Ala Asp Ala Thr Leu He Asn 185 190

GGT CTG GGG CGG TCG GCC TCG ACT CCC ACC GCT GCG CTT GCC GTG ATC 1262 Gly Leu Gly Arg Ser Ala Ser Thr Pro Thr Ala Ala Leu Ala Val He 195 200 205

AAC GTC CAG CAC GGA AAG CGC GTGAGCATTC TCTTGTATGC CATTTCAATG 1313 Asn Val Gin His Gly Lys Arg 210 215

CTTTGTGCTG ACCTATCGGA ACCGCGCAG TAC CGC TTC CGT CTC GTT TCG ATC 1366

Tyr Arg Phe Arg Leu Val Ser He 220

TCG TGT GAC CCG AAC TAC ACG TTC AGC ATC GAC GGG CAC AAC CTG ACC 1414 Ser Cys Asp Pro Asn Tyr Thr Phe Ser He Asp Gly His Asn Leu Thr 225 230 235

GTC ATC GAG GTC GAC GGC ATC AAT AGC CAG CCT CTC CTT GTC GAC TCT 1462 Val He Glu Val Asp Gly He Asn Ser Gin Pro Leu Leu Val Asp Ser 240 245 250 255

ATC CAG ATC TTC GCC GCA CAG CGC TAC TCC TTC GTG GTAAGTCCTG 1508 He Gin He Phe Ala Ala Gin Arg Tyr Ser Phe Val 260 265

GCTTGTCGAT GCTCCAAAGT GGCCTCACTC ATATACTTTC GTTAG TTG AAT GCG 1562

Leu Asn Ala 270

AAT CAA ACG GTG GGC AAC TAC TGG GTT CGT GCG AAC CCG AAC TTC GGA 1610 Asn Gin Thr Val Gly Asn Tyr Trp Val Arg Ala Asn Pro Asn Phe Gly 275 280 285

ACG GTT GGG TTC GCC GGG GGG ATC AAC TCC GCC ATC TTG CGC TAC CAG 1658 Thr Val Gly Phe Ala Gly Gly He Asn Ser Ala He Leu Arg Tyr Gin 290 295 300

GGC GCA CCG GTC GCC GAG CCT ACC ACG ACC CAG ACG CCG TCG GTG ATC 1706 Gly Ala Pro Val Ala Glu Pro Thr Thr Thr Gin Thr Pro Ser Val He 305 310 315

CCG CTC ATC GAG ACG AAC TTG CAC CCG CTC GCG CGC ATG CCA GTG 1751 Pro Leu He Glu Thr Asn Leu His Pro Leu Ala Arg Met Pro Val 320 325 330

GTATGTCTCT TTTTCTGATC ATCTGAGTTG CCCGTTGTTG ACCGCATTAT GTGTTACTAT 1811

CTAG CCT GGC AGC CCG ACA CCC GGG GGC GTC GAC AAG GCG CTC AAC CTC 1860 Pro Gly Ser Pro Thr Pro Gly Gly Val Asp Lys Ala Leu Asn Leu 335 340 345

GCG TTT AAC TTC GTAAGTATCT CTACTACTTA GGCTGGAGGC TCGTCGCTGA 1912 Ala Phe Asn Phe 350

TCATACGGTG CTTCAG AAC GGC ACC AAC TTC TTC ATC AAC AAC GCG ACT 1961 Asn Gly Thr Asn Phe Phe He Asn Asn Ala Thr 355 360

TTC ACG CCG CCG ACC GTC CCG GTA CTC CTC CAG ATT CTG AGC GGT GCG 2009 Phe Thr Pro Pro Thr Val Pro Val Leu Leu Gin He Leu Ser Gly Ala 365 370 375

CAG ACC GCA CAA GAC CTG CTC CCC GCA GGC TCT GTC TAC CCG CTC CCG 2057 Gin Thr Ala Gin Asp Leu Leu Pro Ala Gly Ser Val Tyr Pro Leu Pro 380 385 390 395

GCC CAC TCC ACC ATC GAG ATC ACG CTG CCC GCG ACC GCC TTG GCC CCG 2105 Ala His Ser Thr He Glu He Thr Leu Pro Ala Thr Ala Leu Ala Pro 400 405 410

GGT GCA CCG CAC CCC TTC CAC CTG CAC GGT GTATGTTCCC CTGCCTTCCC 2155 Gly Ala Pro His Pro Phe His Leu His Gly 415 420

TTCTTATCCC CGAACCAGTG CTCACGTCCG TCCCATCTAG CAC GCC TTC GCG GTC 2210

His Ala Phe Ala Val 425

GTT CGC AGC GCG GGG AGC ACC ACG TAT AAC TAC AAC GAC CCG ATC TTC 2258 Val Arg Ser Ala Gly Ser Thr Thr Tyr Asn Tyr Asn Asp Pro He Phe 430 435 440

CGC GAC GTC GTG AGC ACG GGC ACG CCC GCC GCG GGC GAC AAC GTC ACG 2306 Arg Asp Val Val Ser Thr Gly Thr Pro Ala Ala Gly Asp Asn Val Thr 445 450 455

ATC CGC TTC CAG ACG GAC AAC CCC GGG CCG TGG TTC CTC CAC TGC CAC 2354 He Arg Phe Gin Thr Asp Asn Pro Gly Pro Trp Phe Leu His Cys His 460 465 470

ATC GAC TTC CAC CTC GAC GCA GGC TTC GCG ATC GTG TTC GCA GAG GAC 2402 He Asp Phe His Leu Asp Ala Gly Phe Ala He Val Phe Ala Glu Asp 475 480 485 490

GTT GCG GAC GTG AAG GCG GCG AAC CCG GTT CCG AAG GCG TGG TCG GAC 2450 Val Ala Asp Val Lys Ala Ala Asn Pro Val Pro Lys Ala Trp Ser Asp 495 500 505

CTG TGC CCG ATC TAC GAC GGG CTG AGC GAG GCT AAC CAG TGAGCGGAGG 2499 Leu Cys Pro He Tyr Asp Gly Leu Ser Glu Ala Asn Gin 510 515

GCGTGGTGTT GAGCGTAAAG CTCGGGCGTC GACCTGGGGG GTTGAAGGTG TTCTGATTGA 2559

AATGGTCTTT GGGTTTATTT GTTGTTATTC TAACTCGGTT CTCTACGCAA GGACCGAGGA 2619

TTGTATAGGA TGAAGTAACT TCCCTAATGT ATTATGATAT CAATTGACGG AGGCATGGAC 2679

TGCGAAGTGT GTACAATGTG GTAGTGGTCT AGGCCTTGGA GACAAGCTGT GGATTTTTCT 2739

TGGGGGATGA AGAGGCGTGA AGGCTGAGAG CTATGCTATG CCTAGTGACG TGGTTATAGT 2799

AAATGTCCAT TACATTGACC AAGAACGACA AGAACCATAA GCTTGCTGAG GATAGATGGG 2859

GGCGCGTCCG CGAACGACTT G 2880

(2) INFORMATION FOR SEQ ID NO:4:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 519 amino acids

(B) TYPE: amino acid (D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

( i) SEQUENCE DESCRIPTION: SEQ ID NO:4:

Met Gly Leu Gin Arg Phe Ser Phe Phe Val Thr Leu Ala Leu Val Ala 1 5 10 15

Arg Ser Leu Ala Ala He Gly Pro Val Ala Ser Leu Val Val Ala Asn 20 25 30

Ala Pro Val Ser Pro Asp Gly Phe Leu Arg Asp Ala He Val Val Asn 35 40 45

Gly Val Val Pro Ser Pro Leu He Thr Gly Lys Lys Gly Asp Arg Phe 50 55 60

Gin Leu Asn Val Val Asp Thr Leu Thr Asn His Ser Met Leu Lys Ser 65 70 75 80

Thr Ser He His Trp His Gly Phe Phe Gin Ala Gly Thr Asn Trp Ala 85 90 95

Glu Gly Pro Ala Phe Val Asn Gin Cys Pro He Ala Ser Gly His Ser 100 105 110

Phe Leu Tyr Asp Phe His Val Pro Asp Gin Ala Gly Thr Phe Trp Tyr 115 120 125

Ala Asn Pro Val Pro Lys Ala Trp Ser Asp Leu Cys Pro He Tyr Asp 500 505 510

Gly Leu Ser Glu Ala Asn Gin 515

(2) INFORMATION FOR SEQ ID NO: 5:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 3102 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: double

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: DNA (genomic)

(vi) ORIGINAL SOURCE:

(A) ORGANISM: Polyporus pinsitus

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 666..720

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 790..845

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1125..1182

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1390..1450

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1607..1661

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1863..1918

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1976..2025

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 2227..2285

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 2403..2458

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 2576..2627

(ix) FEATURE:

(A) NAME/KEY: CDS

(B) LOCATION: join (665..721, 789..846, 1124..1183, 1389..1451,

1606..1662, 1862..1919, 1975..2026, 2226..2286, 2402..2459, 2575..2628) .

(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5:

TTTCCCGACT AAACCAATCT CAGNCCGCTT CCTCCTAGGG AACCGAGCGA TGTGGCGGCC 60

CTCTCTATCC AAGCTGTCCA TAAGAAGACG TTCAAATGCC GCAGCAAGCG AGGAAATAAG 120

CATCTAACAG TGTTTTTCCC ATAGTCGCAT TTGCGCCGCC TGTCGGACCG ACGCCCCTAG 180

AGCGCTTTGG GAAACGTCGC AAGTGGCGGG TGTTATTCGT GTAGACGAGA CGGTATTTGT 240

CTCATCATTC CCGTGCTTCA GGTTGACACA GCCCAAAGGT CTATGTACGG CCCTTCACAT 300

TCCCTGACAC ATTGACGCAA CCCTCGGTGC GCCTCCGACA GTGCCTCGGT TGTAGTATCG 360

GGACGCCCTA GGATGCAAGA TTGGAAGTCA CCAAGGCCCG AAGGGTATAA AATACCGAGA 420

GGTCCTACCA CTTCTGCATC TCCAGTCGCA GAGTTCCTCT CCCTTGCCAG CCACAGCTCG 480

AG ATG TCC TTC TCT AGC CTT CGC CGT GCC TTG GTC TTC CTG GGT GCT 527 Met Ser Phe Ser Ser Leu Arg Arg Ala Leu Val Phe Leu Gly Ala 1 5 10 15

TGC AGC AGT GCG CTG GCC TCC ATC GGC CCA GTC ACT GAG CTC GAC ATC 575 Cys Ser Ser Ala Leu Ala Ser He Gly Pro Val Thr Glu Leu Asp He 20 25 30

GTT AAC AAG GTC ATC GCC CCG GAT GGC GTC GCT CGT GAT ACA GTC CTC 623 Val Asn Lys Val He Ala Pro Asp Gly Val Ala Arg Asp Thr Val Leu 35 40 45

GCC GGG GGC ACG TTC CCG GGC CCA CTC ATC ACA GGA AAG AAG 665

Ala Gly Gly Thr Phe Pro Gly Pro Leu He Thr Gly Lys Lys 50 55 60

GTATGCTAAG TAGTCCCGCC CCCATCATCC TGTGGCTGAC GTTCGACGCC GCCAG 720

GGT GAC AAC TTC CGC ATC AAC GTC GTC GAC AAG TTG GTT AAC CAG ACT 768 Gly Asp Asn Phe Arg He Asn Val Val Asp Lys Leu Val Asn Gin Thr 65 70 75

ATG CTG ACA TCC ACC ACC ATT GTATGTCACT AGCTCTCGCT ATCTCGAGAC 819

Met Leu Thr Ser Thr Thr He 80

CCGCTGACCG ACAACATTTG CCGTAG CAC TGG CAC GGG ATG TTC CAG CAT 859

His Trp His Gly Met Phe Gin His 85 90

ACG ACG AAC TGG GCG GAT GGT CCC GCC TTT GTG ACT CAA TGC CCT ATC 917 Thr Thr Asn Trp Ala Asp Gly Pro Ala Phe Val Thr Gin Cys Pro He 95 100 105

ACC ACT GGT GAT GAT TTC CTG TAC AAC TTC CGC GTG CCC GAC CAG ACA 965 Thr Thr Gly Asp Asp Phe Leu Tyr Asn Phe Arg Val Pro Asp Gin Thr 110 115 120

GTACGCAAAG GGCAGCATGC GTACTCAAAG ACATCTCTAA GCATTTGCTA CCTAG 1020

GGA ACG TAC TGG TAC CAT AGC CAT CTG GCC TTG CAG TAC TGT GAT GGG 1068 Gly Thr Tyr Trp Tyr His Ser His Leu Ala Leu Gin Tyr Cys Asp Gly 125 130 135 140

CTT CGC GGC CCC CTG GTG ATT TAC GAT CCC CAT GAT CCG CAG GCA TAC 1116 Leu Arg Gly Pro Leu Val He Tyr Asp Pro His Asp Pro Gin Ala Tyr 145 150 155

CTG TAT GAC GTC GAT GAC GTACGCAGCA CAGTTTCCCT AAAACGGTTA 1164

Leu Tyr Asp Val Asp Asp 160

ACTTCTAATT CTGTAAATAT CTTCATAG GAG AGC ACC GTT ATC ACT CTG 1213

Glu Ser Thr Val He Thr Leu 165

GCA GAC TGG TAC CAT ACC CCG GCG CCT CTG CTG CCG CCT GCC GCG 1258 Ala Asp Trp Tyr His Thr Pro Ala Pro Leu Leu Pro Pro Ala Ala 170 175 180

GTACGCCTCC ACACATCTGC ACAGCGTTCC GTATCTCATA CCCTTAAAGT TTATCGGACA 1318

ACT TTG ATT AAT GGC CTG GGT CGC TGG CCT GGC AAC CCC ACC GCC GAC 1366 Thr Leu He Asn Gly Leu Gly Arg Trp Pro Gly Asn Pro Thr Ala Asp 185 190 195 200

CTA GCC GTC ATC GAA GTC CAG CAC GGA AAG CGC GTATGTCATA GCTCGGTTAT 1419 Leu Ala Val He Glu Val Gin His Gly Lys Arg 205 210

CTATTCATAC TCGCGGCCTC GAAGCTAAAA CCTTGTTCCA G TAC CGG TTC CGA 1472

Tyr Arg Phe Arg 215

CTG GTC AGC ACC TCA TGC GAC CCC AAC TAC AAC TTC ACT ATC GAT GGC 1520 Leu Val Ser Thr Ser Cys Asp Pro Asn Tyr Asn Phe Thr He Asp Gly 220 225 230

CAC ACC ATG ACA ATC ATC GAG GCG GAT GGG CAG AAC ACC CAG CCA CAC 1568 His Thr Met Thr He He Glu Ala Asp Gly Gin Asn Thr Gin Pro His 235 240 245

CAA GTC GAC GGA CTT CAG ATC TTC GCG GCA CAG CGG TAC TCC TTC GTT 1616 Gin Val Asp Gly Leu Gin He Phe Ala Ala Gin Arg Tyr Ser Phe Val 250 255 260

GTATGTTTTC CGCATTTCGG GAAAAGGAAT TGCGCTGACA GCTCGAGTGT GCGTAG 1672

CTT AAC GCT AAC CAA GCG GTC AAC AAC TAC TGG ATC CGT GCG AAC CCT 1720 Leu Asn Ala Asn Gin Ala Val Asn Asn Tyr Trp He Arg Ala Asn Pro 265 270 275

AAC CGT GCT AAC ACT ACG GGC TTC GCC AAC GGC ATC AAC TCC GCC ATC 1768 Asn Arg Ala Asn Thr Thr Gly Phe Ala Asn Gly He Asn Ser Ala He 280 285 290 295

CTG CGC TAC AAG GGG GCG CCG ATT AAG GAG CCT ACG ACG AAC CAG ACT 1816 Leu Arg Tyr Lys Gly Ala Pro He Lys Glu Pro Thr Thr Asn Gin Thr 300 305 310

ACC ATC CGG AAC TTT TTG TGG GAG ACG GAC TTG CAC CCG CTC ACT GAC 1864 Thr He Arg Asn Phe Leu Trp Glu Thr Asp Leu His Pro Leu Thr Asp 315 320 325

CCA CGT GCA GTAAGTTCTA CACAGTCACC AACGGTGAGC TGTTGTCTGA 1913 Pro Arg Ala 330

TTGCACTGTG TTATAG CCT GGC CTT CCT TTC AAG GGG GGC GTT GAC CAC 1962 Pro Gly Leu Pro Phe Lys Gly Gly Val Asp His 335 340

GCT TTG AAC CTC AAC CTC ACT TTC GTACGTAGCG CCTCAGATAT CGAGTAGTCT 2016 Ala Leu Asn Leu Asn Leu Thr Phe 345

ATCTCCTGAC CGATTGACAG AAT GGA TCG GAG TTC TTC ATC AAC GAT GCG 2066

Asn Gly Ser Glu Phe Phe He Asn Asp Ala 350 355

CCT TTC GTC CCT CCG ACT GTC CCG GTG CTA CTG CAG ATC CTG AAC GGA 2114 Pro Phe Val Pro Pro Thr Val Pro Val Leu Leu Gin He Leu Asn Gly 360 365 370 375

ACG CTC GAC GCG AAC GAC CTC CTG CCG CCC GGC AGC GTC TAC AAC CTT 2162 Thr Leu Asp Ala Asn Asp Leu Leu Pro Pro Gly Ser Val Tyr Asn Leu 380 385 390

CCT CCG GAC TCC ACC ATC GAG CTG TCC ATT CCC GGA GGT GTG ACG GGT 2210 Pro Pro Asp Ser Thr He Glu Leu Ser He Pro Gly Gly Val Thr Gly 395 400 405

GGC CCG CAC CCA TTC CAT TTG CAC GGG GTAATAATCT CTCTTTATAC 2257

Gly Pro His Pro Phe His Leu His Gly 410 415

TTTGGTCTCC CGATGCTGAC TTTCACTGCT CATCTTCAG CAC GCT TTC TCC GTC 2311

His Ala Phe Ser Val 420

GTG CGT AGC GCC GGC AGC ACC GAA TAC AAC TAC GCG AAC CCG GTG AAG 2359 Val Arg Ser Ala Gly Ser Thr Glu Tyr Asn Tyr Ala Asn Pro Val Lys 425 430 435

CGC GAC ACG GTC AGC ATT GGT CTT GCG GGC GAC AAC GTC ACC GTG CGC 2407 Arg Asp Thr Val Ser He Gly Leu Ala Gly Asp Asn Val Thr Val Arg 440 445 450

TTC GTG GTATGTTTTA CAGCCTCTCT ATCTCCGTGG GCGTTCGGAA GTTGACTGGG 2463 Phe Val 455

GCGTAG ACC GAC AAC CCC GGC CCG TGG TTC CTC CAC TGT CAC ATC GAC 2511 Thr Asp Asn Pro Gly Pro Trp Phe Leu His Cys His He Asp 460 465

TTC CAT TTG CAA GCA GGC CTC GCC ATC GTG TTC GCG GAG GAC GCG CAG 2559 Phe His Leu Gin Ala Gly Leu Ala He Val Phe Ala Glu Asp Ala Gin 470 475 480 485

GAC ACG AAG CTT GTG AAC CCC GTC CCT GTACGTCTTC TGGATGCATG 2606

Asp Thr Lys Leu Val Asn Pro Val Pro 490

CGCTCCGCAC AGTGACTCAT CTTTTGCAAC AG GAG GAC TGG AAC AAG CTG TGC 2659

Glu Asp Trp Asn Lys Leu Cys 495 500

CCC ACC TTC GAT AAG GCG ATG AAC ATC ACG GTT TGAGCGATGC 2702

Pro Thr Phe Asp Lys Ala Met Asn He Thr Val 505 510

GTGGCGCTCA TGGTCATTTT CTTGGAATCT TTGCATAGGG CTGCAGCACG CTGGATACTC 2762

TTTCCCTTAG CAGGATATTA TTTAATGACC CCTGCGTTTA GTGCTTAGTT AGCTTTACTA 2822

CTGGTTGTAA TGTACGCAGC ATGCGTAATT CGGATAATGC TATCAATGTG TATATTATGA 2882

CACGCGTCAT GCGCGATGCT TGAGTTGCAA GGTCGGTTTC CGATGCTCGA CATAAACGTT 2942

TCACTTACAT ACACATTGGG TCTAGAACTG GATCTATCCA TGTATACAAA AACTCCTCAT 3002

ACAGCTGACT GGGGCGCTCT AGAGCATGGG TCCGATTGAT CAGATGTCGC GAACACGAGC 3062

CTCCTGAGCT CGAGGACTCT GAGAAGCGGC GGTGCGTTCT 3102

(2) INFORMATION FOR SEQ ID NO: 6

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 512 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(vi) ORIGINAL SOURCE:

(A) ORGANISM: Polyporus pinsitus

(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6:

Met Ser Phe Ser Ser Leu Arg Arg Ala Leu Val Phe Leu Gly Ala Cys 1 5 10 15

Ser Ser Ala Leu Ala Ser He Gly Pro Val Thr Glu Leu Asp He Val 20 25 30

Asn Lys Val He Ala Pro Asp Gly Val Ala Arg Asp Thr Val Leu Ala 35 40 45

Gly Gly Thr Phe Pro Gly Pro Leu He Thr Gly Lys Lys Gly Asp Asn 50 55 60

Phe Arg He Asn Val Val Asp Lys Leu Val Asn Gin Thr Met Leu Thr 65 70 75 80

Ser Thr Thr He His Trp His Gly Met Phe Gin His Thr Thr Asn Trp 85 90 95

Ala Asp Gly Pro Ala Phe Val Thr Gin Cys Pro He Thr Thr Gly Asp 100 105 110

Asp Phe Leu Tyr Asn Phe Arg Val Pro Asp Gin Thr Gly Thr Tyr Trp 115 120 125

Tyr His Ser His Leu Ala Leu Gin Tyr Cys Asp Gly Leu Arg Gly Pro 130 135 140

Leu Val He Tyr Asp Pro His Asp Pro Gin Ala Tyr Leu Tyr Asp Val 145 150 155 160

Asp Asp Glu Ser Thr Val He Thr Leu Ala Asp Trp Tyr His Thr Pro 165 170 175

Ala Pro Leu Leu Pro Pro Ala Ala Thr Leu He Asn Gly Leu Gly Arg 180 185 190

Trp Pro Gly Asn Pro Thr Ala Asp Leu Ala Val He Glu Val Gin His 195 200 205

Gly Lys Arg Tyr Arg Phe Arg Leu Val Ser Thr Ser Cys Asp Pro Asn 210 215 220

Tyr Asn Phe Thr He Asp Gly His Thr Met Thr He He Glu Ala Asp 225 230 235 240

Gly Gin Asn Thr Gin Pro His Gin Val Asp Gly Leu Gin He Phe Ala 245 250 255

Ala Gin Arg Tyr Ser Phe Val Leu Asn Ala Asn Gin Ala Val Asn Asn 260 265 270

Tyr Trp He Arg Ala Asn Pro Asn Arg Ala Asn Thr Thr Gly Phe Ala 275 280 285

Asn Gly He Asn Ser Ala He Leu Arg Tyr Lys Gly Ala Pro He Lys 290 295 300

Glu Pro Thr Thr Asn Gin Thr Thr He Arg Asn Phe Leu Trp Glu Thr 305 310 315 320

Asp Leu His Pro Leu Thr Asp Pro Arg Ala Pro Gly Leu Pro Phe Lys 325 330 335

Gly Gly Val Asp His Ala Leu Asn Leu Asn Leu Thr Phe Asn Gly Ser 340 345 350

Glu Phe Phe He Asn Asp Ala Pro Phe Val Pro Pro Thr Val Pro Val 355 360 365

Leu Leu Gin He Leu Asn Gly Thr Leu Asp Ala Asn Asp Leu Leu Pro 370 375 380

Pro Gly Ser Val Tyr Asn Leu Pro Pro Asp Ser Thr He Glu Leu Ser 385 390 395 400

He Pro Gly Gly Val Thr Gly Gly Pro His Pro Phe His Leu His Gly 405 410 415

His Ala Phe Ser Val Val Arg Ser Ala Gly Ser Thr Glu Tyr Asn Tyr 420 425 430

Ala Asn Pro Val Lys Arg Asp Thr Val Ser He Gly Leu Ala Gly Asp 435 440 445

Asn Val Thr Val Arg Phe Val Thr Asp Asn Pro Gly Pro Trp Phe Leu 450 455 460

His Cys His He Asp Phe His Leu Gin Ala Gly Leu Ala He Val Phe 465 470 475 480

Ala Glu Asp Ala Gin Asp Thr Lys Leu Val Asn Pro Val Pro Glu Asp 485 490 495

Trp Asn Lys Leu Cys Pro Thr Phe Asp Lys Ala Met Asn He Thr Val 500 505 510

(2) INFORMATION FOR SEQ ID NO:7:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 2860 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 851..905

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1266..1320

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1351..1376

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1416..1468

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1625..1683

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1882..1934

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 2202..2252

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 2370..2425

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 2543..2599

(ix) FEATURE:

(A) NAME/KEY: CDS

(B) LOCATION: join(540..725, 782..850, 906..1025, 1086..1265,

1321..1350, 1377..1415, 1469..1624, 1684..1881, 1935..2201, 2253..2369, 2426..2542, 2600..2653)

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:7:

GGGGGGCGCG TCAATGGTCC GTTTGCGAAC ACATATGCAG GATAAACAGT GCGAAATATC 60

AATGTGGCGG CGACACAACC TCGCCGGCCG ACACTCGACG CTGTTGATCA TGATCATGTC 120

TTGTGAGCAT TCTATACGCA GCCTTGGAAA TCTCAGGCGA ATTTGTCTGA ATTGCGCTGG 180

GAGGCTGGCA GCGCAGATCG GTGTGTCGGT GCAGTAGCCG ACGCAGCACC TGGCGGAAGC 240

CGACATCTCG GGTACGACTT GATCTCCGCC AGATCACTGC GGTTCCGCCA TCGGCCGCGG 300

GGCCCATTCT GTGTGTGCGC TGTAGCACTC TGCATTCAGG CTCAACGTAT CCATGCTAGA 360

GGACCGTCCA GCTGTTGGCG CACGATTCGC GCAGAAAGCT GTACAGGCAG ATATAAGGAT 420

GTCCGTCCGT CAGAGACTCG TCACTCACAA GCCTCTTTTC CTCTTCGCCT TTCCAGCCTC 480

TTCCAACGCC TGCCATCGTC CTCTTAGTTC GCTCGTCCAT TCTTTCTGCG TAGTTAATC 539

ATG GGC AGG TTC TCA TCT CTC .TGC GCG CTC ACC GCC GTC ATC CAC TCT 587 Met Gly Arg Phe Ser Ser Leu Cys Ala Leu Thr Ala Val He His Ser 1 5 10 15

TTT GGT CGT GTC TCC GCC GCT ATC GGG CCT GTG ACC GAC CTC ACC ATC 635 Phe Gly Arg Val Ser Ala Ala He Gly Pro Val Thr Asp Leu Thr He 20 25 30

TCC AAT GGG GAC GTT TCT CCC GAC GGC TTC ACT CGT GCC GCA GTG CTT 683 Ser Asn Gly Asp Val Ser Pro Asp Gly Phe Thr Arg Ala Ala Val Leu 35 40 45

GCA AAC GGC GTC TTC CCG GGT CCT CTT ATC ACG GGA AAC AAG 725

Ala Asn Gly Val Phe Pro Gly Pro Leu He Thr Gly Asn Lys 50 55 60

GTACGTGGCA TGCGTTCAGT CTACACCCTA CAAGCCTTCT AACTCTTTTA CCACAG 781

GGC GAC AAC TTC CAG ATC AAT GTT ATC GAC AAC CTC TCT AAC GAG ACG 829 Gly Asp Asn Phe Gin He Asn Val He Asp Asn Leu Ser Asn Glu Thr 65 70 75

ATG TTG AAG TCG ACC TCC ATC GTATGTGCTT CTACTGCTTC TTAGTCTTGG 880

Met Leu Lys Ser Thr Ser He 80 85

CAATGGCTCA AGGTCTCCTC CGCAG CAT TGG CAC GGC TTC TTC CAG AAG GGT 932

His Trp His Gly Phe Phe Gin Lys Gly 90

ACT AAC TGG GCT GAT GGA GCT GCC TTC GTC AAC CAG TGC CCT ATC GCG 980

Thr Asn Trp Ala Asp Gly Ala Ala Phe Val Asn Gin Cys Pro He Ala 95 100 105 110

ACG GGG AAC TCT TTC CTT TAC GAC TTC ACC GCG ACG GAC CAA GCA 1025

Thr Gly Asn Ser Phe Leu Tyr Asp Phe Thr Ala Thr Asp Gin Ala 115 120 125

GTCAGTGCCT GTGGCGCTTA TGTTTTCCCG TAATCAGCAG CTAACACTCC GCACCCACAG 1085

GGC ACC TTC TGG TAC CAC AGT CAC TTG TCT ACG CAG TAC TGC GAT GGT 1133 Gly Thr Phe Trp Tyr His Ser His Leu Ser Thr Gin Tyr Cys Asp Gly 130 135 140

TTG CGG GGC CCG ATG GTC GTA TAC GAC CCG AGT GAC CCG CAT GCG GAC 1181 Leu Arg Gly Pro Met Val Val Tyr Asp Pro Ser Asp Pro His Ala Asp 145 150 155

CTT TAC GAC GTC GAC GAC GAG ACC ACG ATC ATC ACG CTC TCT GAT TGG 1229 Leu Tyr Asp Val Asp Asp Glu Thr Thr He He Thr Leu Ser Asp Trp 160 165 170

TAT CAC ACC GCT GCT TCG CTC GGT GCT GCC TTC CCG GTAAGTTTAC 1275

Tyr His Thr Ala Ala Ser Leu Gly Ala Ala Phe Pro 175 180 185

CCCAGCGCAC GGAGTTAAGA CCGGATCTAA CTGTAATACG TTCAG ATT GGC TCG 1329

He Gly Ser

GAC TCT ACC CTG ATT AAC GGC GTTGGCCGCT TCGCGGGTGG TGACAG ACT GAC 1382 Asp Ser Thr Leu He Asn Gly Thr Asp

190 195

CTT GCG GTT ATC ACT GTC GAG CAG GGC AAG CGC GTTAGTGATA CCCTCTACAG 1435 Leu Ala Val He Thr Val Glu Gin Gly Lys Arg 200 205

TTGACACTGT GCCATTGCTG ACAGTACTCT CAG TAC CGT ATG CGT CTT CTC TCG 1489

Tyr Arg Met Arg Leu Leu Ser 210 215

CTG TCT TGC GAC CCC AAC TAT GTC TTC TCC ATT GAC GGC CAC AAC ATG 1537 Leu Ser Cys Asp Pro Asn Tyr Val Phe Ser He Asp Gly His Asn Met 220 225 230

ACC ATC ATC GAG GCC GAC GCC GTC AAC CAC GAG CCC CTC ACG GTT GAC 1585 Thr He He Glu Ala Asp Ala Val Asn His Glu Pro Leu Thr Val Asp 235 240 245

TCC ATC CAG ATC TAC GCC GGC CAA CGT TAC TCC TTC GTC GTACGTATTC 1634 Ser He Gin He Tyr Ala Gly Gin Arg Tyr Ser Phe Val 250 255 260

CGAACAGCCA TGATCACGCC AAGCCCGATG CTAACGCGCC TACCCTCAG CTT ACC 1689

Leu Thr

GCT GAC CAG GAC ATC GAC AAC TAC TTC ATC CGT GCC CTG CCC AGC GCC 1737 Ala Asp Gin Asp He Asp Asn Tyr Phe He Arg Ala Leu Pro Ser Ala 265 270 275

GGT ACC ACC TCG TTC GAC GGC GGC ATC AAC TCG GCT ATC CTG CGC TAC 1785 Gly Thr Thr Ser Phe Asp Gly Gly He Asn Ser Ala He Leu Arg Tyr 280 285 290

TCT GGT GCC TCC GAG GTT GAC CCG ACG ACC ACG GAG ACC ACG AGC GTC 1833 Ser Gly Ala Ser Glu Val Asp Pro Thr Thr Thr Glu Thr Thr Ser Val 295 300 305 310

CTC CCC CTC GAC GAG GCG AAC CTC GTG CCC CTT GAC AGC CCC GCT GCT 1881 Leu Pro Leu Asp Glu Ala Asn Leu Val Pro Leu Asp Ser Pro Ala Ala 315 320 325

GTACGTCGTA TTCTGCGCTT GCAAGGATCG CACATACTAA CATGCTCTTG TAG CCC 1937

Pro

GGT GAC CCC AAC ATT GGC GGT GTC GAC TAC GCG CTG AAC TTG GAC TTC 1985 Gly Asp Pro Asn He Gly Gly Val Asp Tyr Ala Leu Asn Leu Asp Phe 330 335 340

AAC TTC GAT GGC ACC AAC TTC TTC ATC AAC GAC GTC TCC TTC GTG TCC 2033 Asn Phe Asp Gly Thr Asn Phe Phe He Asn Asp Val Ser Phe Val Ser 345 350 355

CCC ACG GTC CCT GTC CTC CTC CAG ATT CTT AGC GGC ACC ACC TCC GCG 2081 Pro Thr Val Pro Val Leu Leu Gin He Leu Ser Gly Thr Thr Ser Ala 360 365 370 375

GCC GAC CTT CTC CCC AGC GGT AGT CTC TTC GCG GTC CCG TCC AAC TCG 2129 Ala Asp Leu Leu Pro Ser Gly Ser Leu Phe Ala Val Pro Ser Asn Ser 380 385 390

ACG ATC GAG ATC TCG TTC CCC ATC ACC GCG ACG AAC GCT CCC GGC GCG 2177 Thr He Glu He Ser Phe Pro He Thr Ala Thr Asn Ala Pro Gly Ala 395 400 405

CCG CAT CCC TTC CAC TTG CAC GGT GTACGTGTCC CATCTCATAT GCTACGGAGC 2231 Pro His Pro Phe His Leu His Gly 410 415

TCCACGCTGA CCGCCCTATA G CAC ACC TTC TCT ATC GTT CGT ACC GCC GGC 2282

His Thr Phe Ser He Val Arg Thr Ala Gly 420 425

AGC ACG GAT ACG AAC TTC GTC AAC CCC GTC CGC CGC GAC GTC GTG AAC 2330 Ser Thr Asp Thr Asn Phe Val Asn Pro Val Arg Arg Asp Val Val Asn 430 435 440

ACC GGT ACC GTC GGC GAC AAC GTC ACC ATC CGC TTC ACG GTACGCAGCA 2379 Thr Gly Thr Val Gly Asp Asn Val Thr He Arg Phe Thr 445 450

CTCTCCTAAC ATTCCCACTG CGCGATCACT GACTCCTCGC CCACAG ACT GAC AAC 2434

Thr Asp Asn 455

CCC GGC CCC TGG TTC CTC CAC TGC CAC ATC GAC TTC CAC TTG GAG GCC 2482 Pro Gly Pro Trp Phe Leu His Cys His He Asp Phe His Leu Glu Ala 460 465 470

GGT TTC GCC ATC GTC TTC AGC GAG GAC ACC GCC GAC GTC TCG AAC ACG 2530 Gly Phe Ala He Val Phe Ser Glu Asp Thr Ala Asp Val Ser Asn Thr 475 480 485

ACC ACG CCC TCG GTACGTTGTG CTCCCGTGCC CATCTCCGCG CGCCTGACTA 2582

Thr Thr Pro Ser

490

ACGAGCACCC CTTACAG ACT GCT TGG GAA GAT CTG TGC CCC ACG TAC AAC 2632 Thr Ala Trp Glu Asp Leu Cys Pro Thr Tyr Asn 495 500

GCT CTT GAC TCA TCC GAC CTC TAATCGGTTC AAAGGGTCGC TCGCTACCTT 2683 Ala Leu Asp Ser Ser Asp Leu 505 510

AGTAGGTAGA CTTATGCACC GGACATTATC TACAATGGAC TTTAATTTGG GTTAACGGCC 2743 GTTATACATA CGCGCACGTA GTATAAAGGT TCTCTGGATT GGTCGGACCT ACAGACTGCA 2803 ATTTTCGTGA CCTATCAACT GTATATTGAA GCACGACAGT GAATGGAAAT AGAGACA 2860

(2) INFORMATION FOR SEQ ID NO:8:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 511 amino acids

(B) TYPE: amino acid (D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

( i) SEQUENCE DESCRIPTION: SEQ ID NO:8:

Met Gly Arg Phe Ser Ser Leu Cys Ala Leu Thr Ala Val He His Ser 1 5 10 15

Phe Gly Arg Val Ser Ala Ala He Gly Pro Val Thr Asp Leu Thr He 20 25 30

Ser Asn Gly Asp Val Ser Pro Asp Gly Phe Thr Arg Ala Ala Val Leu 35 40 45

Ala Asn Gly Val Phe Pro Gly Pro Leu He Thr Gly Asn Lys Gly Asp 50 55 60

Asn Phe Gin He Asn Val He Asp Asn Leu Ser Asn Glu Thr Met Leu 65 70 75 80

Lys Ser Thr Ser He His Trp His Gly Phe Phe Gin Lys Gly Thr Asn 85 90 95

Trp Ala Asp Gly Ala Ala Phe Val Asn Gin Cys Pro He Ala Thr Gly 100 105 110

Asn Ser Phe Leu Tyr Asp Phe Thr Ala Thr Asp Gin Ala Gly Thr Phe 115 120 125

Trp Tyr His Ser His Leu Ser Thr Gin Tyr Cys Asp Gly Leu Arg Gly 130 135 140

Pro Met Val Val Tyr Asp Pro Ser Asp Pro His Ala Asp Leu Tyr Asp 145 150 155 160

Val Asp Asp Glu Thr Thr He He Thr Leu Ser Asp Trp Tyr His Thr 165 170 175

Ala Ala Ser Leu Gly Ala Ala Phe Pro He Gly Ser Asp Ser Thr Leu 180 185 190

He Asn Gly Thr Asp Leu Ala Val He Thr Val Glu Gin Gly Lys Arg 195 200 205

Tyr Arg Met Arg Leu Leu Ser Leu Ser Cys Asp Pro Asn r Val Phe 210 215 220

Ser He Asp Gly His Asn Met Thr He He Glu Ala Asp Ala Val Asn 225 230 235 240

His Glu Pro Leu Thr Val Asp Ser He Gin He Tyr Ala Gly Gin Arg 245 250 255

Tyr Ser Phe Val Leu Thr Ala Asp Gin Asp He Asp Asn Tyr Phe He 260 265 270

Arg Ala Leu Pro Ser Ala Gly Thr Thr Ser Phe Asp Gly Gly He Asn 275 280 285

Ser Ala He Leu Arg Tyr Ser Gly Ala Ser Glu Val Asp Pro Thr Thr 290 295 300

Thr Glu Thr Thr Ser Val Leu Pro Leu Asp Glu Ala Asn Leu Val Pro 305 310 315 320

Leu Asp Ser Pro Ala Ala Pro Gly Asp Pro Asn He Gly Gly Val Asp 325 330 335

Tyr Ala Leu Asn Leu Asp Phe Asn Phe Asp Gly Thr Asn Phe Phe He 340 345 350

Asn Asp Val Ser Phe Val Ser Pro Thr Val Pro Val Leu Leu Gin He 355 360 365

Leu Ser Gly Thr Thr Ser Ala Ala Asp Leu Leu Pro Ser Gly Ser Leu 370 375 380

Phe Ala Val Pro Ser Asn Ser Thr He Glu He Ser Phe Pro He Thr 385 390 ' 395 400

Ala Thr Asn Ala Pro Gly Ala Pro His Pro Phe His Leu His Gly His 405 410 415

Thr Phe Ser He Val Arg Thr Ala Gly Ser Thr Asp Thr Asn Phe Val 420 425 430

Asn Pro Val Arg Arg Asp Val Val Asn Thr Gly Thr Val Gly Asp Asn 435 440 445

Val Thr He Arg Phe Thr Thr Asp Asn Pro Gly Pro Trp Phe Leu His 450 455 460

Cys His He Asp Phe His Leu Glu Ala Gly Phe Ala He Val Phe Ser 465 470 475 480

Glu Asp Thr Ala Asp Val Ser Asn Thr Thr Thr Pro Ser Thr Ala Trp 485 490 495

Glu Asp Leu Cys Pro Thr Tyr Asn Ala Leu Asp Ser Ser Asp Leu 500 505 510

(2) INFORMATION FOR SEQ ID NO: 9:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 2925 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: double

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: DNA (genomic)

(Vi) ORIGINAL SOURCE:

(A) ORGANISM: Polyporus pinsitus

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 734..808

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 878..932

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1051..1104

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1219..1270

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1336..1397

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 1713..7744

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 2030..2085

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 2308..2375

(ix) FEATURE:

(A) NAME/KEY: intron

(B) LOCATION: 2492..2569

(ix) FEATURE:

(A) NAME/KEY: CDS

(B) LOCATION: join (733..809, 877..933, 1050..1105, 1218..1271, 1335..1398, 1712..1775, 2029..2086, 2307..2376, 2492..2570) .

2542..2600) .

(Xi) SEQUENCE DESCRIPTION: SEQ ID NO: 9:

CTCATAACTC TTCGCTTCTA GCATGGGGGC TGCGCACACC TGACAGACCC TTCGGGAGGC 60

GAACTCGAAT GCAGCGTACT CTATCNCACC TCCAGGAAAG GTAGGGATGG ACNCCGTGCA 120

CCAACAACTG TCTCTCCACC AGCAACCATC CCTTGGATAT GTCTCCACAC ACCCGGTGTC 180

TACAAGCGGG GATCTGTGCT GGTGAAGTGC TGTCTCCGGA GCGGCGGCGG CGAGCGACCA 240

GAACCCGAAC CAGTGCTAGT GCCCGACACC CGCGAGACAA TTGTGCAGGG TGAGTTATAT 300

TCTTCGTGAG ACGGCGCTGC GCGTCGGCAC TGAAAGCGTC GCAGTTAGGT GATGCAGCGG 360

TCCGCGCTAT TTTTGACGTC TGGCAGCTAT CCTAAGCCGC GCCTCCATAC ACCCCAGGCG 420

CTCTCGTTTG CTATAGGTAT AAATCCCTCA GCTTCAGAGC GTCGATCCTC ATCCCACACG 480

ACACCCGTTT CAGTCTTCTC GTAGCGCATT CCCTAGCCGC CCAGCCTCCG CTTTCGTTTT 540

CAAC ATG GGC AAG TAT CAC TCT TTT GTG AAC GTC GTC GCC CTT AGT CTT 589 Met Gly Lys Tyr His Ser Phe Val Asn Val Val Ala Leu Ser Leu 1 5 10 15

TCT TTG AGC GGT CGT GTG TTC GGC GCC ATT GGG CCC GTC ACC GAC TTG 637

Ser Leu Ser Gly Arg Val Phe Gly Ala He Gly Pro Val Thr Asp Leu 20 25 30

ACT ATC TCT AAC GCC GAT GTT ACG CCT GAC GGC ATT ACT CGT GCT GCT 685

Thr He Ser Asn Ala Asp Val Thr Pro Asp Gly He Thr Arg Ala Ala 35 40 45

GTC CTC GCG GGC GGC GTT TTC CCC GGG CCC CTC ATT ACC GGC AAC AAG 733

Val Leu Ala Gly Gly Val Phe Pro Gly Pro Leu He Thr Gly Asn Lys 50 55 60

GTGAGCCGCG AAACCTTCTA CTAGCGCGCT CGTACGGTGC ACCGTTACTG AAGCCACACT 793

TTGCGCTGTC AACAG GGG GAT GAA TTC CAG ATC AAT GTC ATC GAC AAC CTG 844 Gly Asp Glu Phe Gin He Asn Val He Asp Asn Leu 65 70 75

ACC AAC GAG ACC ATG TTG AAG TCG ACC ACA ATC GTAAGGTGCT TGCTCCCATA 897 Thr Asn Glu Thr Met Leu Lys Ser Thr Thr He 80 85

ATTAAGCCCG TCGCTGACTC GAAGTTTATC TGTAG CAC TGG CAT GGT ATC TTC 950

His Trp His Gly He Phe 90

CAG GCC GGC ACC AAC TGG GCA GAC GGC GCG GCC TTC GTG AAC CAG TGC 998

Gin Ala Gly Thr Asn Trp Ala Asp Gly Ala Ala Phe Val Asn Gin Cys 95 100 105

CCT ATC GCC ACG GGA AAC TCG TTC TTG TAC GAC TTC ACC GTT CCT GAT 1046 Pro He Ala Thr Gly Asn Ser Phe Leu Tyr Asp Phe Thr Val Pro Asp 110 115 120

CAA GCC GTACGTTTAT ACACTTCCCT TTCTGCGGCA TACTCTGACG CGCCGCTGGA 1102

Gin Ala

125

TCAG GGC ACC TTC TGG TAC CAC AGC CAC CTG TCC ACC CAG TAC TGT GAC 1151 Gly Thr Phe Trp Tyr His Ser His Leu Ser Thr Gin Tyr Cys Asp 130 135 140

GGC CTG CGC GGT CCT CTT GTG GTC TAC GAC CCC GAC GAT CCC AAC GCG 1199 Gly Leu Arg Gly Pro Leu Val Val Tyr Asp Pro Asp Asp Pro Asn Ala 145 150 155

TCT CTT TAC GAC GTC GAT GAC GTAAGCAGGC TACTTGTGGA CTTGTATGGA 1250

Ser Leu Tyr Asp Val Asp Asp 160

TGTATCTCAC GCTCCCCTAC AG GAT ACT ACG GTT ATT ACG CTT GCG GAC TGG 1302

Asp Thr Thr Val He Thr Leu Ala Asp Trp 165 170

TAC CAC ACT GCG GCG AAG CTG GGC CCT GCC TTC CCC GTGAGTCTAC 1348

Tyr His Thr Ala Ala Lys Leu Gly Pro Ala Phe Pro 175 180 185

TCTTCCTCGT GTGTTAACAT AGGTGACGGC CGCTGATACG AGAGCTACCA G GCG GGT 1405

Ala Gly

CCG GAT AGC GTC TTG ATC AAT GGT CTT GGT CGG TTC TCC GGC GAT GGT 1453 Pro Asp Ser Val Leu He Asn Gly Leu Gly Arg Phe Ser Gly Asp Gly 190 195 200

GGA GGA GCG ACA AAC CTC ACC GTG ATC ACC GTC ACG CAA GGC AAA CGG 1501 Gly Gly Ala Thr Asn Leu Thr Val He Thr Val Thr Gin Gly Lys Arg 205 210 215 220

GTGAGTCCGC CCTGAGCTGG CCTCAATAGC GATATTGACG AGTCCATGCC CTCCCAG 1558

TAC CGC TTC CGC CTT GTG TCG ATC TCG TGC GAC CCC AAC TTC ACG TTC 1606 Tyr Arg Phe Arg Leu Val Ser He Ser Cys Asp Pro Asn Phe Thr Phe 225 230 235

TCG ATC GAC GGG CAC AAC ATG ACC ATC ATC GAG GTG GAC GGT GTC AAC 1654 Ser He Asp Gly His Asn Met Thr He He Glu Val Asp Gly Val Asn 240 245 250

CAC GAG GCC TTG GAC GTC GAC TCC ATT CAG ATT TTT GCG GGG CAG CGG 1702 His Glu Ala Leu Asp Val Asp Ser He Gin He Phe Ala Gly Gin Arg 255 260 265

TAC TCC TTC ATC GTACGTTCCC TTGCCCTCGT GCTATATCCG CCCGTCTGCT 1754 Tyr Ser Phe He 270

CACAGAGGCT TCTATATCGC AG CTC AAC GCC AAC CAG TCC ATC GAC AAC 1803

Leu Asn Ala Asn Gin Ser He Asp Asn 275 280

TAC TGG ATC CGC GCG ATC CCC AAC ACC GGT ACC ACC GAC ACC ACG GGC 1851 Tyr Trp He Arg Ala He Pro Asn Thr Gly Thr Thr Asp Thr Thr Gly 285 290 295

GGC GTG AAC TCT GCT ATT CTT CGC TAC GAC ACC GCA GAA GAT ATC GAG 1899 Gly Val Asn Ser Ala He Leu Arg Tyr Asp Thr Ala Glu Asp He Glu 300 305 310

CCT ACG ACC AAC GCG ACC ACC TCC GTC ATC CCT CTC ACC GAG ACG GAT 1947 Pro Thr Thr Asn Ala Thr Thr Ser Val He Pro Leu Thr Glu Thr Asp 315 320 325

CTG GTG CCG CTC GAC AAC CCT GCG GCT CCC GGT GAC CCC CAG GTC GGC 1995 Leu Val Pro Leu Asp Asn Pro Ala Ala Pro Gly Asp Pro Gin Val Gly 330 335 340 345

GGT GTT GAC CTG GCT ATG AGT CTC GAC TTC TCC TTC GTGAGTCCCA 2041 Gly Val Asp Leu Ala Met Ser Leu Asp Phe Ser Phe 350 355

CAGCACTCCG CGCCATTTCG CTTATTTACG CAGGAGTATT GTTCAG AAC GGT TCC 2096

Asn Gly Ser 360

AAC TTC TTT ATC AAC AAC GAG ACC TTC GTC CCG CCC ACA GTT CCC GTG 2144 Asn Phe Phe He Asn Asn Glu Thr Phe Val Pro Pro Thr Val Pro Val 365 370 375

CTC CTG CAG ATT TTG AGT GGT GCG CAG GAC GCG GCG AGC CTG CTC CCC 2192 Leu Leu Gin He Leu Ser Gly Ala Gin Asp Ala Ala Ser Leu Leu Pro 380 385 390

AAC GGG AGT GTC TAC ACA CTC CCT TCG AAC TCG ACC ATT GAG ATC TCG 2240 Asn Gly Ser Val Tyr Thr Leu Pro Ser Asn Ser Thr He Glu He Ser 395 400 405

TTC CCC ATC ATC ACC ACC GAC GGT GTT CTG AAC GCG CCC GGT GCT CCG 2288 Phe Pro He He Thr Thr Asp Gly Val Leu Asn Ala Pro Gly Ala Pro 410 415 420

CAC CCG TTC CAT CTC CAC GGC GTAAGTCCTT GCTTTCCTCA GTGCCTCGCT 2339 His Pro Phe His Leu His Gly 425 430

TCCACGACGT CCACTGATCC CACACATCCC ATGTGCAG CAC ACC TTC TCG GTG 2392

His Thr Phe Ser Val 435

GTG CGC AGC GCC GGG AGC TCG ACC TTC AAC TAC GCC AAC CCA GTC CGC 2440 Val Arg Ser Ala Gly Ser Ser Thr Phe Asn Tyr Ala Asn Pro Val Arg 440 445 450

CGG GAC ACC GTC AGT ACT GGT AAC TCT GGC GAC AAC GTC ACT ATC CGC 2488 Arg Asp Thr Val Ser Thr Gly Asn Ser Gly Asp Asn Val Thr He Arg 455 460 465

TTC ACG GTACGTCTTC TCCGGAGCCC TCCCACCCGT GTGTCCGCTG AGCGCTGAAC 2544 Phe Thr 470

ACCGCCCACC GTGCTGCTGC TGCGCAG ACC GAC AAC CCA GGC CCG TGG TTC 2595

Thr Asp Asn Pro Gly Pro Trp Phe 475

CTC CAC TGC CAC ATC GAC TTC CAC CTG GAG GCC GGC TTC GCC ATC GTC 2643 Leu His Cys His He Asp Phe His Leu Glu Ala Gly Phe Ala He Val 480 485 490

TGG GGG GAG GAC ACT GCG GAC ACC GCG TCC GCG AAT CCC GTT CCT 2688

Trp Gly Glu Asp Thr Ala Asp Thr Ala Ser Ala Asn Pro Val Pro 495 500 505

GTACGTCGTG CCTGCTGAGC TCTTTGTGCC CGAACAGGGT GCTGATCGTG CCTTCCTCCG 2748

TGCAG ACG GCG TGG AGC GAT TTG TGC CCC ACT TAC GAT GCT TTG GAC TCG 2798 Thr Ala Trp Ser Asp Leu Cys Pro Thr Tyr Asp Ala Leu Asp Ser 510 515 520

TCC GAC CTC TGATCGACAA GGCATGAAGG CTGAAGCAGC TGCGGTCAAT 2847

Ser Asp Leu

525

TCTCGAACAC ACTTTACTCG AACATTCATT TTTCTTTGGC TCGGGATCGG AACAAATCAT 2907

GGGGGGGCCG GACCGTCT 2925

(2) INFORMATION FOR SEQ ID NO: 10

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 527 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(vi) ORIGINAL SOURCE:

(A) ORGANISM: Polyporus pinsitus

(Xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10:

Met Gly Lys yr His Ser Phe Val Asn Val Val Ala Leu Ser Leu Ser 1 5 10 15

Leu Ser Gly Arg Val Phe Gly Ala He Gly Pro Val Thr Asp Leu Thr 20 25 30

He Ser Asn Ala Asp Val Thr Pro Asp Gly He Thr Arg Ala Ala Val 35 40 45

Leu Ala Gly Gly Val Phe Pro Gly Pro Leu He Thr Gly Asn Lys Gly 50 55 60

Asp Glu Phe Gin He Asn Val He Asp Asn Leu Thr Asn Glu Thr Met 65 70 75 80

Leu Lys Ser Thr Thr He His Trp His Gly He Phe Gin Ala Gly Thr 85 90 95

Asn Trp Ala Asp Gly Ala Ala Phe Val Asn Gin Cys Pro He Ala Thr 100 105 110

Gly Asn Ser Phe Leu Tyr Asp Phe Thr Val Pro Asp Gin Ala Gly Thr 115 120 125

Phe Trp Tyr His Ser His Leu Ser Thr Gin Tyr Cys Asp Gly Leu Arg 130 135 140

Gly Pro Leu Val Val Tyr Asp Pro Asp Asp Pro Asn Ala Ser Leu Tyr 145 150 155 160

Asp Val Asp Asp Asp Thr Thr Val He Thr Leu Ala Asp Trp Tyr His 165 170 175 Thr Ala Ala Lys Leu Gly Pro Ala Phe Pro Ala Gly Pro Asp Ser Val 180 185 190

Leu He Asn Gly Leu Gly Arg Phe Ser Gly Asp Gly Gly Gly Ala Thr 195 200 205

Asn Leu Thr Val He Thr Val Thr Gin Gly Lys Arg Tyr Arg Phe Arg 210 215 220

Leu Val Ser He Ser Cys Asp Pro Asn Phe Thr Phe Ser He Asp Gly 225 230 235 240

His Asn Met Thr He He Glu Val Asp Gly Val Asn His Glu Ala Leu 245 250 255

Asp Val Asp Ser He Gin He Phe Ala Gly Gin Arg Tyr Ser Phe He 260 265 270

Leu Asn Ala Asn Gin Ser He Asp Asn Tyr Trp He Arg Ala He Pro 275 280 285

Asn Thr Gly Thr Thr Asp Thr Thr Gly Gly Val Asn Ser Ala He Leu 290 295 300

Arg Tyr Asp Thr Ala Glu Asp He Glu Pro Thr Thr Asn Ala Thr Thr 305 310 315 320

Ser Val He Pro Leu Thr Glu Thr Asp Leu Val Pro Leu Asp Asn Pro 325 330 335

Ala Ala Pro Gly Asp Pro Gin Val Gly Gly Val Asp Leu Ala Met Ser 340 345 350

Leu Asp Phe Ser Phe Asn Gly Ser Asn Phe Phe He Asn Asn Glu Thr 355 360 365

Phe Val Pro Pro Thr Val Pro Val Leu Leu Gin He Leu Ser Gly Ala 370 375 380

Gin Asp Ala Ala Ser Leu Leu Pro Asn Gly Ser Val Tyr Thr Leu Pro 385 390 395 400

Ser Asn Ser Thr He Glu He Ser Phe Pro He He Thr Thr Asp Gly 405 410 415

Val Leu Asn Ala Pro Gly Ala Pro His Pro Phe His Leu His Gly His 420 425 430

Thr Phe Ser Val Val Arg Ser Ala Gly Ser Ser Thr Phe Asn Tyr Ala 435 440 445

Asn Pro Val Arg Arg Asp Thr Val Ser Thr Gly Asn Ser Gly Asp Asn 450 455 460

Val Thr He Arg Phe Thr Thr Asp Asn Pro Gly Pro Trp Phe Leu His 465 470 475 480

Cys His He Asp Phe His Leu Glu Ala Gly Phe Ala He Val Trp Gly 485 490 495 Glu Asp Thr Ala Asp Thr Ala Ser Ala Asn Pro Val Pro Thr Ala Trp 500 505 510

Ser Asp Leu Cys Pro Thr Tyr Asp Ala Leu Asp Ser Ser Asp Leu 515 520 525

Applicant's or agent's file Intemational application reference number 4185.204-WO to be assigned

PCTIUS 9 5 Q75 ?6

INDICATIONS RELATING TO A DEPOSITED MICROORGANISM

(PCT Rule 13 bis)

For receiving Office use only For Intemational Bureau use only

D This sheet was received with the intemational application D This sheet was received with the International Bureau on:

Authorized officer DoriS L. BrOC' iQ&£>- Authorized officer

PCT Intemational Division

Form PCT/ O/i- (July 1992)

INDICATIONS RELATING TO A DEPOSITED MICROORGANISM

For receiving Office use only For Intemational Bureau use only

G This sheet was received with the international application D This sheet was received with the International Bureau on:

Authorized officer j-^. j_ g _j -Q}. <Ω£S _m _. Authorized officer

PCT International Division

^: orm PCT/ O/13 (July 1992)

Applicant's or agent's file International application N reference number 4185_204- O to be assigned

PCTfUS 9 5 / 07536

INDICATIONS RELATING TO A DEPOSITED MICROORGANISM

(PCT Rule 13 bis)

Applicant's or agent's file International applicanon 1 _/ --_ __, reference number 4185.204-WO to be ass ⁱ gned CT/ US 9 5/ 07536

INDICATIONS RELATING TO A DEPOSITED MICROORGANISM

For Intemational Bureau use only

D This sheet was received with the Intcmauonal Bureau on:

Authorized officer

INDICATIONS RELATING TO A DEPOSITED MICROORGANISM

(PCT Rule 13 bis)

For receiving Office use only For International Bureau use only

D This sheet was received with the intemational application D This sheet was received with the Intemational Bureau on:

Authorized officer Authorized officer

Doris L Brock ( 0 PCT International Division

K5nT MT7ran353r

INDICATIONS RELATING TO A DEPOSITED MICROORGANISM

(PCT Rule 13 bis)

For receiving Office use only For Intemaαonal Bureau use only

D This sheet was received with the intemaαonal application D This sheet was received with the International Bureau on:

Author ⁱ zed officer DorlS L SrCC £k -2 - Authorized officer

PCT International Division or PCT RO/134 (July 1992)